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Resumo  
“Caracterização do potencial patogénico de duas estirpes distintas de Pseudomonas 
aeruginosa” 
 
A Pseudomonas aeruginosa é um patogéneo oportunista e ubíquo, exibindo altos níveis de resistência 
a antibióticos e proliferando em muitos ambientes, incluindo unidades de saúde. A alta infecciosidade deste 
patogéneo em pacientes debilitados e imunocomprometidos, especialmente em pacientes com fibrose cística, 
está associada a altas taxas de morbidade e mortalidade. Não é de estranhar que esta bactéria se tenha tornado 
numa das principais preocupações em termos de infeções hospitalares, e por conseguinte, motivado vários 
trabalhos de caracterização deste patogéneo. 
Uma colaboração entre o Centro de Biologia Molecular e Ambiental da Universidade do Minho e o 
Hospital de Braga permitiu o acesso a dois diferentes isolados clínicos do muco pulmonar dos pacientes 
infetados com Pseudomonas aeruginosa, designados como HB13 e HB15. A estirpe HB13 não produz 
pigmentos e evidenciou resistência a uma ampla gama de antibióticos. Por outro lado, a estirpe HB15 produz 
uma quantidade significativa de piocianina e é suscetível a antibióticos. A estirpe PAO1 da Pseudomonas 
aeruginosa foi utilizada neste trabalho de tese como estirpe de referência. Estas estirpes foram selecionadas 
para avaliar os seus níveis de citotoxicidade nas linhas celulares L929 e A549, por incubação com os fatores 
de virulência segregados. As alterações morfológicas e stress oxidativo induzido nestas linhas celulares foram 
também consideradas neste trabalho de tese. 
Os resultados do estudo de citotoxicidade mostraram que as estirpes de Pseudomonas aeruginosa 
quando proliferando fora de um contexto de infeção, continuam capazes de produzir um conjunto de fatores de 
virulência segregados que induziram altos níveis de inviabilidade celular nas células L929 e A549. De acordo 
com a literatura, estabeleceu-se que a estirpe HB15 é mais patogênica do que a estirpe HB13, demonstrando 
um padrão de patogenicidade semelhante ao da estirpe PAO1. A análise da morfologia das células L929 e 
A549, incubadas com os fatores de virulência das estirpes, por microscopia de contraste de fase e microscopia 
de fluorescência, revelou várias alterações na morfologia celular, tais como aglutinação celular, alteração da 
morfologia celular, formação de corpos apoptóticos, desorganização do citoesqueleto e fragmentação nuclear. 
Os resultados do estudo de stress oxidativo mostraram que, nas fases iniciais de incubação com os fatores de 
virulência das estirpes, as linhas celulares aumentaram a produção de espécies reativas de oxigénio, 
conduzindo a uma intensificação do stress oxidativo, apontado como uma das causas da citotoxicidade das 
estirpes testadas da Pseudomonas aeruginosa. 
Este trabalho de tese abriu caminho para uma melhor compreensão do potencial patogênico destas 
estirpes e trabalhos futuros devem ser direcionados a fim de conseguir-se uma avaliação mais completa dos 
mecanismos e processos celulares subjacentes à patogenicidade destas estirpes.  
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Abstract 
“Pathogenic potential characterization of two distinct Pseudomonas aeruginosa strains” 
 
Pseudomonas aeruginosa is an opportunist and ubiquitous pathogen, displaying high levels of antibiotic 
resistance and proliferating in many environments, including healthcare facilities. The high infectivity of this 
pathogen in impaired and immunocompromised patients, especially cystic fibrosis patients, leads to high rates 
of morbidity and mortality. It is no surprise that this bacterium became one of the main concerns regarding 
nosocomial infections, and so forth driven the attention of many researchers to study and characterize this 
pathogen. 
A collaboration between the Molecular and Environment Biology Centre of the University of Minho and 
the Hospital of Braga, provided two different clinical isolates from the sputum of the patients infected with 
Pseudomonas aeruginosa, classified as HB13 and HB15. The strain HB13 does not produce pigments and 
evidenced resistance to a wide range of antibiotics. On the other hand, the strain HB15 produces a significant 
quantity of pyocianin pigments and is susceptible to antibiotics. The Pseudomonas aeruginosa strain PAO1 was 
used in this thesis work as a reference strain. These strains were selected to assess their levels of cytotoxicity, 
in the L929 and A549 cell lines by incubation with the strains’ secreted virulence factors. Morphological changes 
and oxidative stress induced in these cell lines were also considered in this thesis work.  
The cytotoxicity study outcomes showed that the Pseudomonas aeruginosa strains when growing out of 
an infection context, were still able to produce a set of secreted virulence factors that induced high levels of 
cellular death on L929 and A549 cells. Previous literature established that the HB15 strain is more pathogenic 
than the HB13 strain, demonstrating a pathogenic pattern close to the PAO1 strain. The analysis of the 
morphology of the L929 and A549 cells, incubated with the strains’ virulence factors, by contrast phase 
microscopy and fluorescence microscopy, unveiled several cellular morphology alterations, such as cell 
agglutination, loss of cellular shape, cellular blebbing, evidences of apoptotic bodies, cytoskeleton 
disorganization and nuclear fragmentation. The results of the oxidative stress study showed that in the early 
stages of incubation with the strains’ virulence factors, the cell lines increased the production of reactive oxygen 
species, leading to an intensification of oxidative stress, pointed out as one of the causes of the Pseudomonas 
aeruginosa strains cytotoxicity. 
This thesis work paved the way for perceiving and understanding the pathogenic potential of these 
strains, and future work should be directed in order to achieve a more complete assessment of the mechanisms 
and cellular processes underlying the pathogenicity of these strains.  
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1.1. Bacterial Pathogenesis: an actual and worldwide serious concern 
One of the main afflictions nowadays regarding worldwide public health is the pathogenesis associated 
to the onset of a widespread infectious bacteria. Bacteria causing infectious diseases are one of the major leads 
of worldwide mortality [1]. The World Health Organization (WHO) published statistic data from the leading causes 
of death in the world at the year 2012, where lower respiratory tract infections, majorly caused by pathogenic 
bacteria, was responsible for more than 3 million deaths worldwide, which represents one of the main global 
health threats (Figure 1). Moreover, bacteria pathogenesis are implicated in other main leading causes of death, 
such as diarrhoeal diseases [2]. Another study from WHO stated that infectious diseases are the main cause 
for worldwide deaths of children and young adults. In developing countries, infectious diseases were responsible 
for 45% of all deaths and 63% of all deaths in early infants [3]. These statistic facts enlighten the affect that 
pathogenic bacteria has in global health and why it is an established field of study among researchers and 
regarded under careful surveillance of governments and non-governmental organizations.  
 
Figure 1 - Top leading causes of death in the world 2012. In the bar graphic, it is represent the main leading causes of death 
worldwide, in the year 2012. The first cause is ischaemic heart disease (7.4 million deaths), second it is stroke also known as 
cerebrovascular accident (6.7 million deaths), third it is chronic obstructive pulmonary disease (3.1 million deaths), fourth it is lower 
respiratory infectious (3.1 million deaths), fifth it is trachea, bronchus, lungs cancer (1.6 million deaths), sixth it is HIV/AIDS (1.5 
million deaths), seventh it is diarrhoeal diseases (1.5 million deaths), eighth it is diabetes mellitus (1.5 million deaths), ninth it is road 
injury (1.3 million deaths) and tenth it is hypertensive heart disease (1.1 million deaths). Adapted from World Health Organization, 
Fact Sheet nº 310 (2014) [2]. 
The impact of bacterial pathogenesis, not only lies in the occurrence of new infectious diseases, but 
also in the re-emergence of lethal infectious diseases and in the increasing prevalence of antibiotic resistant 
bacteria strains [1]. 
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The emergence of antibiotic resistant bacteria strains has been established as a main concern in general 
bacterial infections and as an actual and predominant threat to global health. These pathogens are identified as 
multidrug-resistant (MDR) bacteria, also informally known as “superbugs”. These microorganisms are able to 
survive to a generality of antibiotics, at least non-susceptible to 1 or more drugs in 3 or more classes of 
antibiotics, precluding treatment of infectious diseases that culminate in high numbers of morbidity and 
mortality, which make them a serious public health threat, concerning several governments and organizations 
[4], [5]. The world health organization (WHO) has recognized the potential of the impact of these bacteria in 
public health, in its first global report release on antibiotic resistance, shouting that antibiotic resistance problem 
is no longer an issue of the future because it is taking place at the moment all over the world. The WHO assistant 
director-general for health security, Dr. Keiji Fukuda, stated that if there isn’t a synchronized and hurried 
response to the MDR pathogens progress, the world will enter in a “post-antibiotic era” where common illnesses 
will be fatal again. The relevance of this problem of public health has led most of the global microbial research 
to an extensive study of these organisms [6]. 
The emergence of prevalent MDR bacteria has led to outbreaks, generally common in close 
environment, such as hospitals and residual care facilities. In hospitals, the emergence of MDR bacteria is a 
regular occurrence and take the major role concerning the outbreak threat. The disseminated administration of 
antibiotic is a propeller for resistance acquirement and the plentiful vehicles of bacteria dissemination are ideal 
for antibiotic-resistant bacteria to thrive in these environments [7]. Nosocomial infections are infections acquired 
by patients under medical care, also known as healthcare/hospital associated/acquired infections (HAI). These 
kind of infections caused by MDR pathogens turn out to be a major concern in the hospital environment given 
its high prevalence and the increasing rates of morbidity and mortality. Currently, resistant bacteria such as 
methicillin-resistant Staphylococcus aureus (MRSA), vancomycin-resistant Enterococci (VRE), vancomycin-
intermediate Staphylococcus aureus (VISA), multidrug-resistant Acinetobacter baumannii (MRBA) and extended 
spectrum beta-lactamase (ESBL) bacteria, as also multidrug-resistant Gram-negative bacilli like Pseudomonas 
aeruginosa, became common and regular terms of the hospital environment vocabulary. The prevalence of 
these pathogens causing nosocomial infections have become a serious concern. The resistant form of S. aureus 
(MRSA) has had an increasing incidence in the number of hospitalizations in Europe and the United States (US). 
The rates of incidence in the United States of MRSA has already exceed 50% and in some Asian countries the 
rate of incidence came close to 90% [8]. Plus, the WHO shouted that people infected with the resistant form of 
S. aureus (MRSA) are estimated to be 64% more susceptible to decease than people infected with the non-
resistant form [6]. 
The vancomycin-resistant Enterococci (VRE) is one of the currently concerning antibiotic resistant 
pathogen. Data from Centers for Disease Control and Prevention (CDC) in the year of 2004 show that in US the 
VRE caused about 1/3 of the infections in hospital intensive care units [4]. 
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The ESBL infections incidence in hospital environment has reached concerning numbers. In intensive 
care units, in the US, it is estimated a rate of 20% of ESBL Klebsiella pneumoniae infections and a rate of 31% 
of Enterobacter spp infections that now involve resistance to a third-generation cephalosporins [9]. 
One of the most studied MDR bacteria with concerning numbers is the Pseudomonas aeruginosa. This 
bacteria is responsible for 10% of all nosocomial infections. Infections by P. aeruginosa take amplified 
proportions because of its opportunistic characteristic infecting impaired and immunocompromised patients 
raising the mortality rates. Patients with cystic fibrosis are frequently infected with P. aeruginosa, in hospital 
environment. Treatment of these patients was for the first time verified that the constant use of various antibiotics 
led to a sequential emergence of resistance in these bacteria. Also, MDR P. aeruginosa is high transmissible 
among cystic fibrosis patients sometimes leading to outbreaks in clinic context [10]. 
The CDC stated that MDR P. aeruginosa infections represents a high risk of mortality for patients in 
critical care. In US, it is estimated to be 51,000 P. aeruginosa infections in healthcare centres each year, in 
which more than 6,000 of these infections were caused by multi-resistant strains, and culminating in 
approximately 400 death per year [4]. 
In Europe, the European Centre for Disease Prevention and Control (ECDC) published in 2013 a survey 
that estimates that 80,000 patients in European hospitals has a nosocomial infection (1/18 of the all 
hospitalized patients), where the fourth most common microorganisms causing these infections was P. 
aeruginosa with 8,9% of occurrence [11]. In other surveillance report of ECDC, in the year before, the European 
countries displayed worrying reported numbers of MDR P. aeruginosa isolates. In Portugal, 18.1% of the P. 
aeruginosa isolates showed resistance to at least 3 classes of antibiotics, which is fairly concerning (Figure 2) 
[12]. 
 
Figure 2 - Percentage (%) of MDR Pseudomonas aeruginosa isolates by country in Europe, in 2012. Adapted from 
ECDC surveillance report (2013) [12]. 
6 
Furthermore data from National Nosocomial Infections Surveillance system reported that infections by 
P. aeruginosa was the second most common cause of pneumonia (18.1%), the third most common cause of 
urinary tract infections (16.3%) and the eighth most frequently isolated pathogen from the bloodstream (3,4%) 
[13]. 
As the antibiotic resistance in P. aeruginosa is on the increase and given their opportunistic and resilient 
characteristics this bacteria became one of the most concerning issues in pathogenesis at the present time and 
turn the attention of many researchers into getting more knowledge and understanding of this pathogen [10]. 
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1.2. Pseudomonas aeruginosa, the bacterium and the pathogen 
The Pseudomonas aeruginosa species was described for the first time in 1872 by Schroeter. Years 
later, in 1882, Gessard isolated in pure culture these bacteria from the surface of wound exacerbations in a 
form of a “blue-green pus”. Afterwards, this bacterium species was continuously studied [14], [15]. 
The Pseudomonas aeruginosa is a bacillus shaped gram-negative bacterium with an aerobic 
metabolism, having mostly only one flagellum (Figure 3). These bacteria have a remarkable and versatile 
metabolism which allows it to survive and proliferate in numerous environments, from soil to the human 
organism [16]–[18]. This biological success of Pseudomonas aeruginosa has taken advantage from its huge 
genomic and metabolic potential. The first sequenced Pseudomonas aeruginosa strain, PAO1, revealed 6.3 
million base pairs, including 5,570 predicted open reading frames (ORF), which contains a large fraction of 
transcriptional regulators or two-component regulatory systems (about 10%), that engender a facilitated adaptive 
physiological response [19]. 
 
Figure 3 – Scanning electron microscopy images of Pseudomonas aeruginosa bacteria. Image of adherent isolate of 
Pseudomonas aeruginosa forming clumps of cells. White bar indicates the image scale (1 µm). Adapted from Deligianni (2010) [20]. 
Metabolically, this bacterium can utilize a variety of different carbon sources to survive. Despite of its 
characterized aerobic metabolism, Pseudomonas aeruginosa can respire under anaerobic conditions using 
nitrogen as an alternative carbon source. It can also subsist with minimal nutrient requirement and can keep 
growing through temperatures up to 42˚C [21]. 
This bacterium belongs to the Proteobacteria phylum the large bacteria phylum that includes a large 
variety of known pathogens. In this group, Pseudomonas aeruginosa appears as a ubiquitous and opportunistic 
pathogen that infects several organisms including the human organism. In the era of antimicrobial research, P. 
aeruginosa turns to be one of the main agents of nosocomial infections causing morbidity and mortality in the 
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hospital infected patients [22]. The way of infecting of this bacterium is the great example of an opportunistic 
agent action rarely infecting healthy patients, waiting for the moment when the host organism becomes feeble 
to attack [23]. This is observable in several clinical cases like pneumonia, urinary tract infections, surgical wound 
infections, bloodstream infections. Imunocompromised patients, like in cases of bone marrow transplants, 
neutropenic cancer, burns and AIDS, are also susceptible to this pathogen infection action. In patients suffering 
from cystic fibrosis, P. aeruginosa represents the most common pathogen that leads to the progression of this 
disease and death [24]. 
Pseudomonas infections can be classified into chronic and acute infections. In chronic infections the 
pathogen lives inside the host during long periods of time. On the other hand, the acute infections like pneumonia 
and urinary tract infections are categorized by a quick bacterial progression and growth, leading in some cases 
to septicaemias and to host death [22].  
The versatility of the P. aeruginosa as an opportunistic and resistant pathogen supports the interest of 
scientific research about this bacteria potentialities and their large field of applications ranging from their 
associated pathogenicity and clinical concern to biotechnological and biomedical applications. Within this range, 
the most prominent point of focus in P. aeruginosa research interests is its infectiousness [25]. 
1.2.1. Pathogenicity 
P. aeruginosa is an opportunistic pathogen that leads to much discussion and concern as it became 
one of the most dangerous and recurrent agent of infection in hospital environments [22]. Its status as a major 
opportunistic human pathogen is due to its antibiotic and disinfectant resistance that eradicates other 
environmental bacteria [19]. The immune condition of the host and the given environment influence the attack 
mechanism of Pseudomonas aeruginosa which can behave as quiescent colonizer, a highly virulent invader 
during acute infection or cause of chronic infection (Figure 4) [25]. In some human cases have been described 
the colonization in chronic obstructive pulmonary disease by P. aeruginosa, the abrupt and acute ventilator-
associated pneumonia in respiratory tract of patients and also chronic infections in cystic fibrosis patients that 
lead to a progressive and deteriorating lung function [26]. Its infectivity potential comes in part from a large sort 
of virulence factors derived from P. aeruginosa versatile and flexible genome, where 10% of its genes are 
organized in “pathogenic genomic islands” [21]. 
This fact triggers a combined effort between extensive molecular, biologic, clinical and therapeutic 
research to better understand the pathogenicity potential of P. aeruginosa [22]. 
There is a large set of pathogenic features underlying the overall infectious capacity of P. aeruginosa. 
The combination of the several pathogenic determinants of the P. aeruginosa is assumed to be more relevant 
to the infectious success than the effect of one given infectious element, and the mechanisms of the combined 
action of the different pathogenic features is very relevant to research [21]. 
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Figure 4 - Model of Pseudomonas aeruginosa pathogenicity in an immunocompromised host's infection. The figure 
represents the pathogenic features of P. aeruginosa following a context of infection in a cystic fibrosis patient airways. Pathogenic 
features such as arranged colonization, cell-associated virulence factors, secreted virulence factors, production of biofilms and 
antibiotic resistance are illustrated in the figure enhancing the infection development in the debilitated host. Adapted from Cohen 
(2012) [27].  
1.2.1.1. Virulence factors 
One of the most infectious characteristics of P. aeruginosa is its associated virulence factors. Factors 
such bacterial surface components and lipopolysaccharide (LPS), as well as secreted toxins and enzymes, 
enhance the impact of P. aeruginosa in infections [26]. 
These factors can be categorized into secreted virulence factors or cell-associated virulence factors [24]. 
1.2.1.1.1. Cell-associated virulence factors 
The several cell-associated virulence factors of P. aeruginosa are essential for the bacterial colonization 
process. The components of the cell structure of P. aeruginosa that have virulence potential include motility 
prompters such as pili and flagella, delivery systems that carry effector proteins into the host cells and LPS 
which has capacity to block the host immune response and also contribute to the maintenance of persistent 
infections [28], [29]. 
Type IV pili (Tfp) are polarity localized cell appendages constituted by pili polymers having the capacity 
of reversible assemblage and disassembling, providing to P. aeruginosa movement across solid surfaces, 
process called twitching motility (Figure 5). This feature confers P. aeruginosa the ability to move or glide through 
nutritional and environment signals and enables biofilm formation as well fast colonization on surfaces [30]. Tfp 
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can act as a phage receptor playing roles in early biofilm formation and adhesion to mammalian cells. In many 
studies was found glycosphingolipids as host receptors for Tfp, in bacteria binding to the apical surface of host 
polarized cells, though the binding mechanism is not yet totally clear [31]. The connexion of P. aeruginosa with 
host cells seems to modulate the Tfp expression, when the bacteria binds to the host cell the expression of pili 
proteins is instantly annulled [29]. 
 
Figure 5 - Type IV pilli. Illustrate representation of the type IV pilus mechanism. In the inner membrane the pilin monomer is 
embedded with its hydrophilic head placed in the periplasm. The pillin signal sequence is cleaved by a pre-pilin peptidase (PilD). The 
pilus is extended aided by supplementary assembly proteins. After extension is done, the retraction starts by action of PilT. Adapted 
from Kaiser (2000) [32]. 
The bacterial flagellum is a polymer composed of flagellin, often presented in P. aeruginosa as a single 
polar unit [31]. It is a product of the fliC gene, though other genes products are necessary to the flagellar self-
construct [33]. Structurally is an organelle consisting in a filament with a connecting hook, bond to the cell 
surface by a basal body embedded in it (Figure 6) [24], [30]. P. aeruginosa flagella are essential for cell 
swimming and swarming motility, adhesion to cells and biofilm formation. Also the flagella constituent, 
monomeric flagelin, is detected by the innate immune system, either by recognition of individual subunits by 
intracellular cytosolic sensors or by ligation to Toll-like receptor 5 (TLR5) at the cell surface [31]. 
There is still incomplete understanding about the mechanistic and structural details of the interaction 
of flagella with the host epithelium. The flagellar cap protein (FliD) of the P. aeruginosa strain O1 (PAO1), but 
not other strains, demonstrated to be involved in bacterial adherence to mucin on the respiratory tract, by 
binding to LewisX oligosaccharides and glycolipids receptors [24], [31]. 
LPS are key cell-associated factors in virulence and both innate and acquired host responses to infection. 
In outer-membrane of P. aeruginosa LPS is a main component composed by Lipid A, a hydrophobic domain, 
and a hydrophilic tail of core polysaccharides and O-specific polysaccharide coming out from the cell surface 
[24], [34]. 
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In summary, these cell-associated virulence factors aid P. aeruginosa in colonization of host organisms, 
helping the bacteria to adhere and invade breaking the host immune responses and blocking the antibiotic’s 
action [21].  
 
Figure 6 - Schematic representation of Pseudomonas aeruginosa flagellum. Structure of the P. aeruginosa flagellum 
embedded in the cell wall and membrane and its components. Adapted from EMBL-EBI BioModels Database (2012) [35].  
In terms of pathogenicity conferred by virulence factors, there are other P. aeruginosa features that have 
special relevance in the mechanisms of infection which are related with the bacterial population activity and 
interactions. 
1.2.1.1.2. Secreted virulence factors 
Several extracellular factors are secreted by P. aeruginosa after colonization with the potential to cause 
extensive tissue damage, bloodstream invasion and dissemination. The type of infection may vary with the given 
factor contribution, associated to systems involving cell-to-cell signalling [21]. 
Proteases among other virulence factors play a major role in acute infection. There are four types of 
proteases currently known to be secreted: protease IV, alkaline protease, LasA elastase and LasB elastase 
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(staphylolysin). These secreted proteases improve the capacity of the P. aeruginosa to invade cellular tissues 
and block mechanisms of defence [21], [36]. 
The destruction of elastin is a major virulence feature of the P. aeruginosa in acute infections. This 
protein is one of the main components of the cell tissues of the lungs responsible for the organ expansion and 
contraction. This protein is also an essential component responsible for blood vessels’ resilience [21]. 
The two proteases LasA and LasB give a defined elastolytic activity when acting together. This lytic 
action is acknowledged to destroy elastin-containing human lung tissue and cause pulmonary haemorrhages. 
LasA elastase is a zinc metalloendopeptidase, also known as staphylolysin. This elastase is one of the most 
abundant secreted virulence factors of P. aeruginosa. Its action consists in cleaving the elastin, turning it 
susceptible to degradation by other proteases, like LasB and neutrophil elastase, and alkaline protease. LasB 
elastase is a zinc metalloprotease acts in many other proteins besides elastin. This enzyme is highly effective, 
with about ten times of the alkaline protease lytic activity and an activity against casein four times that of trypsin 
[37]. These two proteases, LasA and LasB, were found in the mucus of the lungs of cystic fibrosis (CF) patients. 
The role of one of these elastases, LasB, in tissue destruction of cystic fibrosis remains less understood. The 
wide range of action of this enzyme permits not only to destroy tissue structures but also disturbing the infected 
organism defense mechanisms. In animal study models, P. aeruginosa mutants of LasB elastase are less 
pathogenic than the parental strains, sustaining the LasB crucial function as a virulence factor [25], [38]. 
The alkaline protease (AprA) also called aeruginolysin belongs to the subfamily B of the M10 peptidase 
family, included in the metzincin superfamily. This enzyme is a zinc-dependent metallo-endopeptidase secreted 
by P. aeruginosa [38]. One of the AprA targets is laminin which is an essencial component of the basal lamina 
of cellular tissues. AprA and LasB have the capacity of inactivate human γ-interferon and human necrosis factor-
α responsible for effective host immune response [38].  
Also, AprA and LasB can inhibit neutrophils’ function affecting their chemotaxis providing bacteria with 
more chances to escape by affecting the phagocytic activity of leucocytes, through cleavage of cell receptors. 
Natural killer (NK) cells are also affected by inhibition of the effector/target cell conjugate formation. Furthermore 
the alkaline protease can inactivate different human protease inhibitors and degrade cytokines such as 
interleukin-6 [38].  
The protease IV, also called lysyl endopeptidase or iron-regulated protein PrpL, is a serine protease 
secreted by P. aeruginosa, belonging to the chymotrypsin family S1. This protease has the capacity of cleavage 
of bovine fibrinogen, a large biopolymer and part of the blood coagulation system. Disruption on the fibrinogen 
integrity leads to haemorrhages in the host. Plasminogen, immunoglobulin G (IgG), complement components 3 
and C1q are also degradation targets for protease IV that interferes with the host immune system [38]. 
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One of the known secreted virulence factors is Exotoxin A (ETA). This toxin has the ability to blockade 
protein synthesis and lead to cell death, via ADP-ribosylation and inhibition of the elongation factor 2 (EF2). 
Local tissue damage is one of the consequences of ETA action, from renal-necrosis and liver cell-necrosis to 
lung haemorrhage. In CF patients, this exotoxin has its main role in bacterial invasion and immunosuppression 
[39]. 
P. aeruginosa has a delivery mechanism for virulence factors, the type III secretion system (TTSS or 
T3SS) that transports exoenzimes to the host cells (Figure 7). These are four enzymes: exoenzyme S (ExoS), 
exoenzyme T (ExoT), exoenzyme U (ExoU) and exoenzyme Y (ExoY) which they are expressed inequality in 
different isolates [40]. In a study conducted by Feltman et al., it was concluded that all isolates contained ExoT 
whereas the presence of other exoenzymes seemed to be reciprocally exclusive [41].  
 
Figure 7 - Model of type III secretion system (TTSS) function. The figure represents the TTSS divided into 5 components: the 
regulatory proteins, the effector proteins, the chaperones, the needle complex and the translocation apparatus. The aseemble of this 
5 components makes the TTSS function and allows the injection of effector proteins into the host cells. Adapted from Hauser (2009) 
[42]  
The virulence mechanisms of these exoenzymes are distinct. While the ExoS and ExoT acts in the 
damage of the cytoskeleton of the host cells by disrupting the actin assemblage, leading to programmed cell 
death, the ExoU make host sensible to secondary infections. ExoY raises the levels of intracellular cyclic AMP 
(cAMP) which in turn damages the actin cytoskeleton, indirectly [24].  
The bacterial surfactants named rhamnolipids are virulence factors frequently secreted by P. 
aeruginosa. Their action is related to the development and maintenance of biofilms and in ex-vivo studies showed 
to interfere with cell-to-cell communication, by modulating and disrupting tight junctions of respiratory epithelial 
cells [43]. 
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Pyoverdin and Pyochelin are two secreted siderophores responsible for the recruitment of iron by the P. 
aeruginosa. Iron is necessary for bacterial growth and an increase in its intracellular accumulation enhances 
the persistence of infections [44]. 
Pyocianin is a blue greenish, chloroform-soluble pigment synthesized by P. aeruginosa responsible for 
the typical blue colour in wound pus. Apart from the colour feature of this pigment, it possesses virulence 
potential causing the inhibition of epidermal cell growth, cell respiration in mammalian and prokaryotic cells, 
and plays a central role in lung infections and in iron acquisition. Also, catalase expression is repressed by 
pyocianin [45]. 
 
Figure 8 - Pseudomonas aeruginosa culture in agar plate displaying pyocyanin production. Adapted from Mavrodi (2001) 
[46]. 
It was demonstrated in P. aeruginosa pyocianin-mutant isolates that it has minor virulence aptitude than 
the wild type strains using mice models as hosts. Despite the reduced pathogenic potential compared to the 
wild type strains, the mutant strains were still capable of causing local inflammation, to the significance of the 
infectious capacity of other virulence factors [45], [47]. 
Other virulence factors secreted by P. aeruginosa contribute to its pathogenicity capability, such as 
phospholipase C, histamine and leukocidin, although few information is available [24]. 
Besides the wide panoply of virulence factors, P. aeruginosa have other characteristics that confer very 
unique pathogenicity to this bacterium. Among them, the best known are the capacity of producing biofilms and 
quorum sensing, a special extracellular communication.  
1.2.1.2. Biofilms 
Biofilm assemblage is a remarkable feature of P. aeruginosa that boost survival capacity and adaptation 
of this bacteria. The formation of biofilms is included in stages of the bacterial life of P. aeruginosa, committed 
to some substrate or surface, or in a planktonic form, as a single organism, actively swimming using its motility 
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organs. These surface communities are organized in cell agglomerates involved by its self-produced polymeric 
matrix which give adherent proprieties to a variety of surfaces [24], [48]. 
P. aeruginosa biofilm physiology has a complex structure whereas cells show a heterogeneous 
physiological status determined by the position of each individual cell inside the different layers of cells 
composing the biofilm. In the surface layers of the biofilm, cells have more easy access to nutrients and oxygen 
and, as they are metabolically active, they have reduced concerns with the release of metabolic waste products 
[49]. 
The development of P. aeruginosa biofilms is divided in five stages (Figure 9) [50], [51]. The first stage 
is the reversible attachment, where planktonic cells attach to the substratum by flagella. P. aeriginosa is able of 
freely attachment and disattachment to the substratum [50]. The second stage is the irreversible attachment, 
in this step bacteria cells can lose its flagella due to a reorientation of the cell axis and so ending the motility 
ability. Afterwards, bacteria agglomerate and form microcolonies. In this phase, type IV pili plays an important 
role by preserving the twitching motility. Upon definitive attachment, P. aeruginosa initiates protein expression 
of the genes algC, algD and algU responsible for the synthesis of alginate’s extracellular matrix component [52]. 
The third stage is early maturation, when there is an exponential upregulation of genes and the involvement of 
proteins responsible for anaerobic processes [52]. The fourth stage is the definitive maturation where the biofilm 
has its maximum thickness and structurally adopts a multicellular mushroom-shaped assembly, depending on 
the medium existent nutrients [24], [53]. The last stage is the detachment phase where single or grouped cells 
can detach from the biofilm and leave to form new biofilms. The swimming ability of P. aeruginosa and the 
matrix enzyme degradation are important factors for the dispersion and detachment of bacteria cells from the 
biofilm [52].  
 
Figure 9 - Biofilm development. The figure represent the 5 stages of the biofilm development. (1) First stage of biofilm 
development, the initial attachment. (2) Second stage of biofilm development, the irreversible attachment. (3) Third stage of biofilm 
development, the initial phase of maturation. (4) Fourth stage of biofilm development, the definitive phase of maturation. (5) Fifth 
stage of biofilm development, the dispersion. Adapted from Monroe (2007) [51]. 
Bacteria can thrive in a roll of nutrient-sufficient environment when organized in biofilms that enhance 
the capacity to resist to antibiotics and disinfectants, beyond this biopolymer coats such as exopolysaccharide 
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(EPS) matrix that encase the P. aeruginosa biofilms confers protection from host immune mechanisms. In 
summary, biofilm structures are inherent to P. aeruginosa survival even under stringent conditions [54]. 
1.2.1.3. Quorum sensing 
Several bacteria cells developed a system of stimulus and response to the presence of other same cells 
recognized as quorum sensing (QS). By this system, bacteria cells are able to communicate with each other 
and regulate gene expression [55]. Autoinducers are signal molecules self-generated by bacteria involved in QS 
that allow monitoring of the cell population density. When a maximum concentration of autoinducers is reached, 
target genes expression is altered by specific receptor binding. Therefore population density will control the 
induction or repression of defined genes, while affecting the cell population behavior [45]. Beyond the population 
density monitoring, QS signal molecules can regulate the expression of several secreted virulence factors as 
also control the formation of Pseudomonas aeruginosa biofilms [55]. 
Three distinct quorum sensing systems have been described up to now. The rhl and las are two N-acyl 
homoserine lactone (AHL)-dependent QS system, each one involving respectively the autoinducers N-butyryl-L-
homoserine lactone (PAI-2) and the N-(3-oxo-dodecanoyl)-L-homoserine lactone (PAI-1). These two systems are 
organized in an established hierarchy, and more than 10% of the P. aeruginosa genome is regulated by their 
signal pathways [45], [55], [56]. The third QS system is a 2-alkyl-4-quinolone (AQ)-dependent system, related 
with the signal systems such as Pseudomonas quinolone signal (PQS) and the HHQ precursor. Other factors 
are susceptible to manipulate the activity of the QS systems like GacA/GacS and PhoB/PhoR two component 
system and transcriptional factors such as PqsR and Vfr [45], [55]. 
The pathogenic features of P. aeruginosa hereby presented cannot be effective if the pathogen is not 
able to survive under counter procedures. In the clinical environment, the bacterial pathogenicity is often 
contended with antibiotic administration. However, the given pathogenicity of P. aeruginosa is complemented 
with a persevering resistance against several antibiotics that make these bacteria so hazardous. 
1.2.1.4. Antibiotic resistance 
Antibiotics have been the main weapon against pathogenic microorganisms since the early 1940s after 
the advent of penicillin discovery [57]. Administration of antibiotics as treatment of infectious diseases proved 
to be a clinical success, although researchers stated that this success came out with the price of drug-resistance 
[58]. The acquisition of drug-resistance by these microorganisms may have different origins. The direct cause 
of drug-resistance induction bases in the own microorganism exposure to the antibiotic that causes a natural 
selection of the individuals with genes for resistance, which leads to a dissemination of these resistance genes 
through the bacteria population. The plasticity of the bacteria genome also represents a main factor for 
acquisition of drug-resistance caused by spontaneous or induced mutations. Also, bacteria can acquire 
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resistance genes from other bacteria by either horizontal gene transfer or transmissible plasmids. Most of these 
plasmids contain genes conferring multiple resistance to several antibiotics [59]. 
The extensive use of antibiotics for infection treatments induced a selective pressure on bacterial 
populations that allowed resistant individuals to thrive (Figure 10). Generalized resistance induced over antibiotic 
administration became worryingly common, demanding alternatives and different treatment approaches. 
Nevertheless, the continuous administration of antibiotics ultimately resulted in even more resistant strains [60]. 
 
Figure 10 - Bacterial population variations induced by antibiotic action. Bacteria with acquired antibiotic resistance (red 
coloured) compete with the susceptible counterparts in their population niche. (1) When in absence of antibiotic administration, the 
resistant bacteria will not predominate unless they have a higher inherent biological fitness. Plus, the acquirement of resistance to 
antibiotics generally represents a loss of biological fitness. (2) When there’s an administration of antibiotic the susceptible bacteria 
growth is inhibited which turns in an ecological opportunity for the resistant bacteria to thrive. (3) Under this conditions the resistant 
bacteria will proliferate and dominate the bacterial population. After the population is absent from the antibiotic action the bacterial 
population may return to its original scenario and the dominance of the resistant bacteria disappear. (4) Alternatively the resistant 
bacteria may acquire compensatory mutations which will maintain a noticeable occurrence of the resistant bacteria among the 
bacterial population. Adapted from Martínez (2007) [61]. 
As it is already known, P aeruginosa is one of the main pathogens responsible for nosocomial infections. 
This status is in large part due to its antibiotic resistance or also called multidrug-resistance phenotype [29]. 
The broad resistance of P. aeruginosa it is associated with a combinatorial factors such as the innate resistance 
to antibiotic agents due to outer-membrane low permeability, the genetic capacity to express an expansive stock 
of resistance mechanisms, the acquisition of mutation in chromosomal genes regulating resistance genes and 
the acquirement of additional resistance genes from other organisms via plasmids, bacteriophages and 
transposons [62]. 
P. aeruginosa’s associated resistance is frequently categorized into intrinsic/innate resistance and 
acquired or mutational resistance [29], [63]. The innate resistance is related to general adaptive processes 
which is independent of the category of antibiotic [64]. On the other hand, the acquired resistance mechanism 
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is a feature of the P. aeruginosa obtained by mutations in the genomic material content such as addition of new 
DNA, as also by incorporation of transposons, integrons and plasmids [64]. Internal changes in the regulatory 
systems of the bacteria could also play a role in the resistance to antibiotics [65].  
There are three main antibiotic resistance mechanisms associated to P. aeruginosa: drug inactivation, 
restricted uptake and efflux and changes in targets [62].  
One of the intrinsic resistance features of the P. aeruginosa is the capability of producing an AmpC-like 
inducible chromosomal ß-lactamase that hydrolyse ß-lactams, inactivating it. The ß-lactams, such as ceftazidime, 
meropenem, piperacillin, aztreonam and imipenem, disrupt the assemblage of the bacterial cell wall by inhibiting 
the peptidoglycan-assembling transpeptidases in the outer layer of the cytoplasmatic membrane. The bacterium 
cell exposure to some ß-lactams will induce production of ß-lactamases, which ultimately will result in an 
increased resistance to the inducing ß-lactams and other ß-lactams. The chromosomal AmpC ß-lactamase is 
normally regulated by induction, although mutations may alter its mechanism of induction. It is a common case 
of mutation resistance of P. aeruginosa strains, the derepression of ß-lactamases associated with the inactivation 
of the ampD gene, which in clinical context is the most common case of ß-lactams resistance in these bacteria 
[62], [63]. 
The distinctive structure of the P. aeruginosa’s outer-membrane is one of the main features of its 
intrinsic resistance. The combination of restricted uptake through the outer-membrane with energy-dependent 
efflux systems represents a barrier to the inflowing of a range of antimicrobials in the pathogenic cell. The low 
permeable outer-membrane play a major role in antibiotic resistance because agents that break down the outer-
membrane make the cells more susceptible to antibiotics. The structure of the outer-membrane in gram-negative 
cells is composed by a phospholipid bilayer that contains porins forming water-filled channels as the major path 
for diffusion of hydrophilic molecules. In P. aeruginosa, the OprF is the major porin that allows the efflux of large 
compounds such as tri-saccharides and tetra-saccharides, and possibly some antibiotics, however it forms 
majorly small channels that reject the efflux of the molecules referred above [63]. 
The low permeability of the outer-membrane alone does not confer a proper resistance mechanism, in 
fact its main function is decreasing the rate of antibiotic uptake keeping a slow efflux despite the external 
antibiotic concentration and therefore the secondary resistance mechanisms, such as antibiotic efflux or 
degradation, can work more efficiently. It has been described that two efflux systems play an important role in 
intrinsic antibiotic resistance given their constitutive expression and influence of inhibitors and knockout 
mutations. The first system described was the MexAB-OprM system, a RND (resistance-nodulation-division) 
system with 3 constituent proteins, the MexB, a cytoplasmic pump protein, the MexA a periplasmic linker protein 
and the OprM an outer-membrane protein. This pump system is capable to efflux a broad range of antibiotics 
such as chloramphenicol, tetracyclines, sulfamethoxazole, trimethoprim, quinolones and some ß-lactams, 
although it is ineffective against other antibiotics such as erythromycin, aminoglycosides, polymyxins or 
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imipenem and other ß-lactams. The second efflux system described is the MexX-MexY conjoining with OprM. 
The wide analysis of this system reveals that many substrates of the MexAB-OprM are extruded by MexX-MexY, 
although with a main role in the intrinsic resistance to erythromycin and aminoglycosides [63]. After these two 
efflux pumps, much more were identified and described playing important roles in the extrusion of antimicrobials 
[63], [66]. Regulatory mutations on nalB (mexR) lead to overexpression in the MexAB-Opr efflux system, other 
regulatory mutations lead also to overexpression to other efflux systems. The up-regulation of these efflux pumps 
are one of the main mutational resistance of P. aeruginosa and confer resistance to fluoroquinolones, 
cephalosporins, some ß-lactams and also aminoglycosides [63], [67].  
The most common resistance mechanism of P. aeruginosa by changes in the target are structural 
modification in the enzyme DNA gyrase, thwarting the action of quinolones. The majority of the reported cases 
describe a missense in the gyrA subunit (gyrA) of the DNA gyrase at codon 83 (quinolone target). Other 
mutations are occasionally noticed, by instance in higher levels of resistance its observable mutations in the 
DNA gyrase subunit B (gyrB) or in the topoisomerase IV (parC), which are target sites that alter susceptibility to 
all quinolones [63], [67]. 
As it is mentioned above, these resistance mechanisms, especially involving mutational resistance 
mechanisms, opposes to several frequently administered anti-Pseudomonas antibiotics, precluding clinical 
treatments and increasing morbidity and mortality rates (Table 1) [62].  
Alongside the resistance mechanisms already described, P. aeruginosa’s biofilm structure is referred 
as a resistance mechanism by itself. Once a population of P. aeruginosa aggregates assemble into a biofilm 
structure, the encased cells are protected by an alginate polysaccharide, which confers to the population a 
recalcitrant property against physical and biochemical aggressions, including antibiotics. On the other hand, 
studies demonstrate that specific compounds present in the biofilm have a more specific interaction with 
antibiotics. Findings of Man et al., demonstrated that periplasmic glucans produced in the biofilm are 
responsible for sequestering antimicrobial agents in the periplasm avoiding it to reach its active sites [62], [68]. 
Through the years, the established pathogenicity of P. aeruginosa has been the focus of several studies 
about infectious mechanisms, virulence factors and antibiotics resistance. The research, up to now, performed 
on bacteria pathogenicity has recurred to the use of selected biological models in order to evaluate the 
associated infectiveness and potential lethality, which open various paths to reach a more complete 
understanding of the P. aeruginosa pathogenic mechanism. 
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Table 1 - Major resistance mechanisms to antipseudomonal antibiotics. Adapted from Hancock (2000) [63]. 
Class Agents Resistance Mechanisms/Comments 
Penicillin Ticarcillin Derepression of chromosomal b-lactamase.Overexpression of the 
MexAB-OprM multidrug efflux pump due to a NalB mutation. 
Specific plasmid-mediated b-lactamases. 
Carbenicillin 
Piperacillin 
Cephalosporin Ceftazidime Derepression of chromosomal b-lactamase.Overexpression of the 
MexAB-OprM multidrug efflux pump due to a NalB mutation. For 
the fourth generation cephalosporins cefepime and cefpirome, 
overexpression of the MexCD-OprJ multidrug efflux pump due to 
an NfxB mutation. 
Cefoperazone 
Cefepime 
Cefpirome 
Aminoglycoside Gentamicin Overexpression of the MexXY efflux pump in impermeability type-
resistance due to a mutation in the regulatory gene MexZ. Tobramycin 
Amikacin Plasmid-mediated production of modifying enzymes. 
Quinolone Ciprofloxacin Target site mutations in the GyrA (or sometimes the GyrB) 
topoisomerase subunit; Overexpression of multidrug efflux 
pumps due to NalB, NfxB or NfxC mutations. 
Polymyxin Colistin Outer membrane LPS changes due to PhoP/PhoQ regulatory 
mutations. No evidence this occurs in the clinic. 
Carbapenem Imipenem Loss of specific outer membrane porin channel, OprD; Reduction 
in levels of OprD due to an NfxC mutation that also upregulates 
multidrug resistance due to MexEF-OprN; For meropenem 
overexpression of the MexAB-OprM multidrug efflux pump due to 
a NalB mutation. 
Meropenem 
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1.3. Bacterial Strains 
The term “bacterial strain” has been used to classify a subset population of bacterial species, which 
differs from other bacteria species in minor identifiable characteristics and features. Literature references such 
from Staley et al. [69], defined strain as “…made up of the descendants of a single isolation in pure culture and 
usually is made up of a succession of cultures ultimately derived from initial single colony” and Tenover et al. 
[70], which defined strain as “…an isolate or a group of isolates that can be distinguished from other isolates 
of the same genus and species by phenotypic characteristics or genotypic characteristics or both”. Strains can 
be of natural occurrence or created in laboratory by mutagenizing the wild-type existing bacteria species. The 
upsurge of strains, may lead to having, inside the same species, populations of bacteria displaying particular 
different functions from its counterparts, such as having a pathogenic population vs. a non-pathogenic 
population [71]. 
At present day, there are hundreds of identified and characterized strains of Pseudomonas aeruginosa. 
The adaptability and plasticity of its genome is one of the main features responsible for the dissemination and 
proliferation of numerous different strains [72]–[75]. It is no surprise that is found in the P. aeruginosa species 
such divergent strains in genomic and phenotypic features. Within the P. aeruginosa species it is verified highly 
pathogenic strains as PA14 strain, moderate pathogenic strains as PAO1 and non-pathogenic strains as ATCC 
15442 [76], [77]. 
1.3.1. Pseudomonas aeruginosa strains 
Through the genomic era, bacterial characterization such identifying bacteria at the strain level or 
bacterial strain typing, became a main issue due to the importance for diagnosis, treatment and epidemiological 
surveillance of bacterial infections. This level of bacterial characterization is significant for bacteria strain 
classification and expose the genetic diversity undiscovered in important phenotypic features [78]. 
In the year 2000, the first Pseudomonas aeruginosa genome was completely sequenced using the strain 
PAO1. This strain is regarded as the P. aeruginosa common reference strain, initially a spontaneous 
chloramphenicol-resistant mutant of the original PAO strain (previously called “Pseudomonas aeruginosa strain 
1”) isolated from an infected burn wound of a patient in Melbourne, Australia in 1954 (ATCC 15692). Since 
then, this strain from Bruce Holloway’s laboratory was the main work strain for Pseudomonas genetics and 
functional analyses [79], [80]. 
At the time, the genome of PAO1 was the largest bacterial genome sequenced with 6.3 million base 
pairs (Figure 11). The genome sequence of PAO1 enlightened our knowledge in Pseudomonas aeruginosa 
bacterial versatility, pathogenicity and its inherent antibiotic resistance, such is the revealing of outer membrane 
proteins (OMPs) and efflux systems genes involved in transport of antibiotics [19]. 
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Figure 11 - Genome representation of PAO1. The outer circle is a base pair scale (each tick equivalent to 100,000 bp) that 
represents the chromosomal location. The colour distribution of the central circle represents genes according to its functional category. 
The arrow in the representation stands for the direction of transcription (the inner band represents the minus strand, the outer band 
represents the plus strand). Green arrow represents the inverted region resulting from homologous recombination event between rrnA 
and rrnB. Red arrows represent transcription direction and locations of rRNA genes. Blue arrows represents locations containing 
probable bacteriophages. The inner black band represents the G+C percentage schemed as the average for non-overlapping 1000 bp 
windows spanning one strand for the entire P. aeruginosa genome. Yellow bars represents genome regions of ≥ 3000 bp with G+C 
content of two standard deviations (<58.8%) below the mean (66.6%). Adapted from Stover (2000) [19]. 
The full sequencing of the PAO1 make way for full genome sequencing of other P. aeruginosa strains 
central in laboratorial research (Table 2). The PA14 and LESB58 strains were the following P. aeruginosa strains 
genome to be fully sequenced, and alongside PAO1 strain they were used as laboratorial strain references for 
structural and functional studies, as well as pathogenic studies [76], [81], [82]. 
The PA14 was the next full sequenced genome of a P. aeruginosa strain after PAO1 sequencing. 
Alongside the PAO1 used as the main reference P. aeruginosa strain in laboratory, the PA14 has become to be 
used as a laboratory reference P. aeruginosa strain for studies of pathogenicity and virulence. The PA14 strain 
presents a substantial higher virulence than its counterpart, PAO1, displaying the capacity of infecting a broad 
cast of hosts, such as mammals, insects, nematodes and plants [76], [83]. The PA14 strain high virulence is 
correlated with particular sets of pathogenic genes within its genome. The full sequencing of its genome revealed 
two major sets of pathogenic genes defined as pathogenic islands and absent in the PAO1 genome. These two 
Pseudomonas aeruginosa pathogenic islands are PAPI-1 and PAPI-2 with 108 kb and 11 kb, respectively. They 
display high modular structures, mobile elements and complex derivations from other bacterial species. 
23 
Furthermore, a majority of its genes are homologous with genes in other human and plants pathogens. The 
virulent arsenal encoded by this PAPIs is one of the main sources for highly virulent P. aeruginosa strains [81], 
[84]. 
Table 2 - Pseudomonas aeruginosa fully sequenced genomes. 
Strain Size (Mbp) GC content (%) Year Genbank number Reference 
PAO1 6.3 66.6 2000 NC_002516 [19] 
PA14 6.5 66.3 2006 NC_008463 [83] 
LESB58 6.6 66.3 2009 NC_011770 [82] 
PA7 6.6 66.4 2010 NC_009656 [85] 
M18 6.3 66.5 2011 NC_017548 [86] 
NCGM2.S1 6.8 66.1 2011 NC_017549 [87] 
DK2 6.4 66.3 2012 NC_018080 [88] 
 
The LESB58 is a high virulent P. aeruginosa strain first found in a Liverpool cystic fibrosis clinic facility 
for children in 1996, identified as Liverpool epidemic strain (LES). Its epidemic nature turn this strain famed for 
transfer between patients with cystic fibrosis to patients without cystic fibrosis, raising significant numbers of 
morbidity. In comparison to PAO1, this strain shows a higher transmissible, an advanced aggressive feature, a 
superior virulence, a wider spectrum of antibiotic resistance and conceivably an enhanced aptness to cystic 
fibrosis lung patients. In infection context, the LESB58 strain persevered in the bronchial lumen while the PAO1 
and PA14 strain grew in macrocolonies after some days postinfection in the alveolar regions. Also, the LESB58 
strain produce more biofilm than the PAO1 and PA14 strain [81], [82]. The hyper virulence and the enhanced 
lung colonization feature of the LESB58 strain is attributable to pathogenic islands as in the PA14 strain, and 
also transcriptional variations at gene level expression. The genomic sequence of LESB58 exposed many large 
genomic islands (GI), counting 5 prophage clusters, 5 non-phage islands and 1 defective prophage cluster, some 
unique and others showing similarities with previous identified P. aeruginosa GIs [81], [82].  
P. aeruginosa adaptable genome and its diversity of strains is a main issue concerning development, 
ecology and epidemiology of infectious diseases, which led efforts to establish links between distinct strains and 
search for better insights regarding infection process in the patient, aiming for improved prognostics and better 
patient care. Recently, in 2015, the International Pseudomonas aeruginosa Consortium (IPC) revealed a 
genomic study that allowed to group with an unmatched resolution the P. aeruginosa strains. This consortium 
is sequencing over a thousand genomes and developing an user-friendly analysis pipeline for the study of the 
Pseudomonas genome evolution [75].  
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Comparative genomic approaches led to identification of several changes in P. aeruginosa genome such 
as loss of virulence traits, improved antibiotic resistance, changes in surface antigens, increased production of 
alginate and modulation of metabolic pathways [89].  
The evaluation of these changes is important to allow comparison of: virulence factors, shift of function 
mutations, antibiotic resistance genes, complete and accessory genomes. The IPC, aiming for fine-scale 
analyses to evaluate these changes, used 389 genomes and performed a phylogenetic analysis of the core 
genome of the P. aeruginosa strains. The results showed that the P. aeruginosa strains can be divided into 3 
major groups and, subsequently, into further subgroups (Figure 12). The high number of strains and the 
extensive assortment of sources where these strains came from, such as clinical, environmental and animal 
strains, and also, the wide geographic distribution, suggests a tree arrangement where the group 1, which 
includes PAO1 and LESB58 strains, the most abundant group, followed by the group 2, which includes PA14 
strain, and then the group 3 including the PA7 strain [75]. 
 
Figure 12 - Pseudomonas aeruginosa strains phylogenetic tree. The tree presented is an unrooted maximum likelihood tree 
representing 389 genomes of P. aeruginosa strains, based on SNPs within the core genome, using Harvest method (100 bootstraps). 
The tree is divided into three major groups of strains (group 1: blue, group 2: orange/pink, group 3: green). The strains distributed for 
each group are presented in circles. Black circles represent the strains already sequenced before the Freschi et al. study [75]; White 
circles represent one or more strains sequenced during Freschi et al. study [75]. The group 3 true appearance was contracted for 
visual proposes, the miniature of the tree true appearance is displayed in a framed miniature. Adapted from Freschi et al., 2015 [75]. 
The data analysis of this genomic study revealed also that the core genome represents 17.5% of the 
average P. aeruginosa genome size, reflecting the high diversity of P. aeruginosa strains. Furthermore, the 
25 
identification of resistance genes in P. aeruginosa genome revealed that, approximately, 40% of the detected 73 
resistance genes were spotted in a majority of strains, while, approximately, 60% of the resistance genes were 
discovered only in a restricted group of strains, underlining the pronounced variability of P. aeruginosa strains 
regarding the resistance genes [75]. 
1.3.1.1. Clinical isolates HB13 and HB15 
The healthcare facilities are a fertile environment for the occurrence of a novel identifiable bacterial 
strains obtained under the form of clinical isolates. Every year in hospitals and clinics across the globe it is 
delivered numerous clinical isolates of Pseudomonas aeruginosa infections, where it is identifiable new strains 
or strain variants [90]–[93]. 
A partnership between the Centre of Molecular and Environmental Biology, University of Minho (CBMA 
– UM) and the Hospital of Braga, located in the city of Braga, north Portugal, handle about 500 clinical isolates 
of P. aeruginosa each year. The objective is a complete research methodology in order to obtain significant 
information and methods for genomic, functional and structural studies of these P. aeruginosa isolates [94].  
The Pathology Service at the Hospital of Braga categorized the P. aeruginosa isolates into three classes 
according antibiotic susceptibility: pan-resistant isolates (displaying a broad resistance towards antibiotics and 
also are checked positive for metallo-beta-lactamases (MBLs)); multi-resistant isolates (displaying resistance 
toward at least 3 antibiotics and checked positive for MBLs); susceptible isolates (did not display an evident 
antibiotic resistance and checked negative for MBLs). The isolates susceptibilities towards antibiotics were 
accessed using the frequently third-generation cephalosporin Ceftazidime and ß-lactams Imipenem and 
Piperacillin/Tazobactam, the aminoglycosides Tobramycin, Amikacin and Gentamicin and the fluroquinolone 
Ciprofloxacin. Furthermore phenotypic studies and analysis were carry out in CBMA laboratories, for instance, 
motility assays (swarming, swimming and twitching), production of virulence factors (pigments, elastase, flagella 
and toxins), biofilm formation and exopolysaccharide production. Plus, virulence assays were performed with 
animal models (nematode Caenorhabditis elegans and the insect larvae Galleria mellonella) [94], [95]. 
Throughout a seasonal epidemiological survey carry out in the collaboration CBMA-UM/Hospital of 
Braga it was selected two particular isolates, the HB13 and the HB15 for further analysis (Table 3). These 
isolates were both collected from sputum of the lungs of pneumonic patients in the Hospital of Braga. The HB13 
displayed an allelic representative type ST175 associated with multidrug resistance, it did not produce pigments, 
exhibiting a low level of virulence and demonstrated an antibiotic-panresistant phenotype. The HB15 displayed 
a rare allelic representative type ST560, it produced a large quantity of pyocyanin, exhibiting a high level of 
virulence and was susceptible to all antibiotics testes. Both HB13 and HB15 genomes were full sequenced 
revealing the estimated genome sizes, 6,357.409 bp and 6,813.259 bp, respectively, where is evident a 
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difference of about 0.5 Mbp between the two isolates. The GC content give roughly the same 66.2% for both 
isolates [94], [95].  
A comparative genomic study on these strains revealed that the HB13 strain presented a genetic 
background more identical to the strains PAO1 and LESB58, with 98.8% pairwise identity, which is included in 
the group 1 of the P. aeruginosa strains. On the other hand, the HB15 strain presented more similarity with the 
PA14 strain, with 98.5% pairwise identity, putting it in the group 2 [75], [95]. 
Table 3 – Comparison summary of general features between the two clinical isolates HB13 and HB15. 
 HB13 HB15 
Allelic sequence type ST175 ST560 
Antibiotic resistance Pan-resistant Susceptible 
Infection context Pneumonia Pneumonia 
Infection type Multi-infection (E. coli) Mono-infection 
Source Sputum Sputum 
Pyocyanin production Not detectable Present 
Genome size 6,357.409 bp 6,813.259 bp 
Strain genomic group Group 1 Group 2 
 
Further genomic comparative analysis revealed evidences of the accessory genomes of both isolates. 
In the HB13 isolate it is verified unique genes related with antibiotic resistance (for instance puromycin N-
acetyltransferase-like gene), transposase elements and phages. In the HB15, instead, was verified unique genes 
for arsenic and chromate resistance and cell wall assembling (for instance glycosyltransferases) [94], [95]. 
The unique features of these clinical isolates and their infections context enlighten the importance of a 
complete and exploitative research, aiming for achieve relevant information regarding the pathogenic potential 
of these isolates and their impact in healthcare facilities. Pathogenicity studies relies frequently in host models 
to access levels of virulence of a determined microorganism.  
 
  
27 
1.4. Bacterial infection mechanisms and host models 
The bacterial pathogenesis relies its harmfulness and capacity of host damage in a variety of infection 
mechanisms which can aid, both the pathogens in its way invading and binding to the host and in avoiding the 
host defence systems [1], [96]. Currently, significant evidences regarding the bacterial pathogenesis disclosed 
that many different pathogens share common infection strategies and mechanisms in order to harm the host 
and avoid its defences. Analogous infection mechanisms shared by different pathogens are associated with the 
acquirement of virulence genes from common bacterial ancestors. In turn, these virulence genes can be 
disseminated to other bacteria via horizontal transfer. Furthermore, horizontal transfer of virulence determinants 
is also responsible for pathogenic mechanisms common to different bacterial pathogens and directly associated 
to the onset of new pathogenic bacteria strains [1], [96]. 
There is a variety of mechanisms and process in which the bacterial pathogen can infect the host and 
evade its defences. In Figure 13, it is presented a summary of common infection mechanisms between bacterial 
pathogens. The bacterial pathogens infecting the host, may either induce several host responses and use its 
infection mechanisms to evade host defences, and/or adhere to the host surface in order to further invade host 
cell tissue, as well, invade the intracellular domain [1].  
When encountering the host the bacterial pathogen use general processes, such as avoiding 
phagocytosis, prompting a septic shock by severe systemic inflammatory response, invading and damaging host 
cells and binding to host surface [1], [97].  
One of the features of the bacterial pathogens responsible for evading host defences is the capsule. The 
bacterial capsule is a large structure enveloping the bacterial cell, characteristic of gram-positive bacteria. The 
capsule is constituted by a polysaccharide layer, also called exopolysaccharides (EPS), and it is consider a 
virulence factor because its ability of preventing the pathogen phagocytosis [98], [99]. Different species of 
bacteria may have the ability to use diverse types of sugar to produce the capsule. The capsule enables the 
bacterial pathogen to evade the host immune response, as well, protection from antibiotics. Moreover, some 
capsules displayed immunomodulatory effects on the host. In detail, the capsule avoid the pathogen to be 
phagocytosed by disabling the recognition of opsonising antibodies by phagocytic cells such as macrophages 
and neutrophils. This traduces in a “frustrated phagocytosis” that leads to a boosted inflammatory response, 
meanwhile, the phagocytic cells produces more cytokines in order to eliminate the bacteria, which by its turn, 
induces an increased tissue damaging, given the arriving of cumulative phagocytic cells into the infection site 
[1]. 
The bacterial cell wall is a rigid structure inclosing the cell membrane of the bacteria. It provides a 
structural and protection support to the bacteria, and acting as a pressure vessel disabling the over-expansion 
of the cell volume [100], [101].  
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Figure 13 – Summary of the bacterial mechanisms for pathogenicity. (A) Bacterial pathogens finding a human host may 
induce a set of host responses and counter with several host defence evading mechanisms. The components from the pathogen that 
interact with the host include: (I) the capsule, which “frustrate” the phagocytic function and protect the pathogen from neutrophil and 
macrophage engulfment; (II) lipopolysaccharides (LPS) and cell wall components which may lead to septic shock; (III) toxins 
responsible for host cell damage and aiding in invasion; and (IV) adhesins that eases the binding of the pathogen with the host surface. 
In what level these mechanisms intervene in the pathogenesis of the infection is dependent of some factors such as bacterial species 
and strains, immune status of the host and pathogen entry site. (B) When the bacterial pathogen adheres to the host surface it can 
break into cell tissue by expressing and secreting proteases and glycanases that destroy the extracellular matrix. Furthermore, the 
pathogen invading cell tissue is also able to access intracellular domain. This process can be aided by action of natural phagocytosis 
mechanisms of macrophages and neutrophils or by action of an induced uptake where pathogen induce the host cell to engulf the 
adhered bacteria. One of the most common methods of the pathogens to induce uptakes is the type III secretion system which injects 
bacterial signalling proteins into the host cells. When inside the host cell, the pathogen can reside in the cell host cytosol or as a 
phagosome or even as a phagolysome (a lysosome fused with hagosome). Adapted from Wilson et al., 2002 [1].  
The bacterial cell wall is mainly composed of peptidoglycan and its structure differs in gram-positive 
bacteria and gram-negative bacteria. The gram-positive bacteria cell wall is a thick layer, mainly composed with 
peptidoglycan and teichoic acid. In the other hand, the gram-negative bacteria cell wall is a relatively thin layer 
composed with a peptidoglycan layer surrounded with a second lipid membrane containing several components 
such as lipoproteins and lipopolysaccharides (LPS) [100], [102]. Much of these gram-negative cell wall 
components are strong virulence factors, playing effective roles in the bacterial septic shock, which may, easily, 
lead to a collapse of the circulatory system of the host and multiple organ failure. The bacterial virulence 
components of the cell wall are distinct structures, rarely secreted to the extracellular domain, until the bacteria 
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death and cell lysis. Paradoxically, the administration of antibiotics to treat the bacterial sepsis may lead to a 
release of virulence components of the cell wall which worsen the host convalescence [1].  
The septic shock consists in an inflammatory mechanism mediated by cytokines, complement 
components, and the coagulation cascade. The realising of lipopolysaccharides (LPS) constituents of the 
bacterial cell wall is a major agent in triggering the inflammatory response leading to the septic shock. As 
described before, the LPS, also called endotoxins, are large amphophilic molecules located in the outer 
membrane of the bacterial cell wall, which activates inflammatory pathways leading to both innate and acquired 
host responses to infection [1], [100]. 
A battery of toxins are the arsenal of many bacterial pathogens in order to invade and cause damage to 
the host cells. Generally, the bacterial toxins are divide into proteinaceous, such as exotoxins and non-
proteinaceous toxins, such as LPS. Regarding the proteinaceous toxins, they are generally enzymes which have 
the capacity to infect the host cell, either by secretion into the cell surrounding environment or by direct injection 
into the intracellular domain assisted with a delivery mechanisms, such as type III secretion system (TTSS). 
These toxins are common in several bacterial organisms and its function consists frequently in break down 
extracellular matrix and disruption of the cytoplasmic membrane. Furthermore, there are toxins that degrade 
immunoglobulins, such as immunoglobulin A, toxins that activate guanylate cyclase and toxins that affects the 
host cell cytoskeleton [1], [25], [38], [103].  
Other important bacterial pathogen components in the infection context, is the adhesins. These 
components are cell surface appendages of the bacteria, which can be polypeptides or polysaccharides, and 
have the function of facilitating the adherence and binding of the pathogen to the host surface. Host surfaces 
may include, mucous membranes, deeper tissues and skin. Many host mechanical responses act against this 
bacterial adherence to the tissues, such as sneezing, coughing, mucous flow, blood flow, saliva production and 
gastric system movements. Although, bacterial pathogens developed a common trait where it expresses factors 
with the ability to bind to a variety of host tissues and promotes the resilience of the pathogen during the 
infection. When the pathogen is adhered to the host surface, it is triggered specific biochemical processes that 
will ultimately lead to bacterial proliferation, host cell invasion, toxin secretion and host cell signalling pathways 
[1], [104], [105]. 
When the pathogen adheres to the host surface, it becomes more accessible the infiltration of the 
pathogen further into the host cell tissue, leading to a higher endurance of the bacterial infection. Generally, the 
bacterial invasion of the host cell tissues can be classified as extracellular invasion or intracellular invasion. In 
extracellular invasion, the bacterial pathogens uses a set of enzymes that break down the host molecules and 
the host tissue barriers, leading to the advance of the pathogen further into the host extracellular domain while 
outside the host cells. The pathogen infiltration into the host tissues enables the pathogen to find niches in the 
tissues suitable for proliferation, evasion for other body parts, toxin secretion and trigger immuno-inflammatory 
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responses. In intracellular invasion, the pathogen is able to break into the cells of the host tissue. Many bacterial 
pathogens have been reported to break into host cells, both phagocytic and non-phagocytic cells. Bacterial 
pathogens lifecycle can be dependent of an intracellular residence, been obligated to invade a host cell in order 
to growth, as also, bacterial pathogens can be optionally intracellular, enter in the host cells as a mean to 
proliferate and invade other tissues. In addition to host intracellular invasion by phagocytosis of the pathogen, 
some bacterial pathogens are able to express molecular injection mechanisms, such as type III secretion system 
(TTSS). This mechanism injects into the cell proteins that triggers signalling pathways, ultimately leading to the 
incorporation of the pathogen in the intracellular domain, which often causes a disruption of the host cell 
cytoskeleton [1], [106], [107].  
Bacterial pathogens residing within the host cell can be found in phagolysosomal vacuole, in a 
phagosome or living in the host cell cytosol. The phagolysosomal vacuole presents an acidic environment and 
hydrolytic functions. Some bacterial pathogens reside in this harsh vacuole environment and it is demonstrated 
that its low pH is required to trigger intracellular replication. The phagosome are frequently referred as a vacuole 
that was not fused with a lysosome. These vacuoles are occupied by pathogens, which leads to morphological 
differences from the other cellular vacuoles as also a characteristic set of surface markers. Some bacterial 
pathogens exhibits enzymatic mechanisms that digest the enveloping vacuole and allows it to proliferate into 
the host cell cytosol via cytoskeleton. The ability of bacterial pathogens to reside within the host cells may induce 
intracellular replication, which leads to proliferation in the infection area, as well, migration to other body parts 
[1], [107]–[110].  
Comprehending the complexity of host-pathogen interaction require a wide range of possible host 
models and analytical methods. Through evolutionary course, certain virulence mechanisms and host responses 
have been conserved, enabling various organisms to be used as hosts for better understanding of infection 
mechanisms [111].  
1.4.1. Infection host models 
Several biological models are applicable to a variety of bacterial pathogens in order to study its infection 
mechanisms. The models for study P. aeruginosa infections mechanisms, as also, effects of virulence factors 
and lethality to the host, extends, not only, from animal models, such as mammals, fishes, insects, and 
nematodes (Table 4). But also, from mammalian cell lines, and even, plant models. These models beyond 
providing important resource for the development and experiment of new treatments, also offer important data 
about the beginning and development of the bacteria establishment and infection [112].  
Mammal host models are the most widely and characterized models to study infection mechanisms 
leading to human disease. Unlike other models, mammals have both innate and adaptive immune systems, 
allowing an understanding of host-pathogen relationship at system level. One of the most important features of 
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the mammal host models is its route of infection which mimics the natural route of infection, since this would 
guarantee that the pathogen met proper barriers to infection. Models have been developed in sense of closely 
reflecting the natural routes of dissemination and infection [113]. 
Table 4 - Comparison between different animal host model features for studying infection mechanisms. 
PARAMETERS Rodents Zebrafish G. mellonella D. melanogaster C. elegans 
Size 10 cm 6.4 cm 2 cm 2.5 mm 1 mm 
Generation time 10 weeks 3-4 months 30 days 10 days 4 days 
Ease of handling Difficult Easy Easy Very easy Very easy 
Costs High Low Low Low Low 
Space requirements Major Minor Minor Minor Minor 
High throughput No Yes Yes Yes Yes 
Speed of outcome Months Days Days Days Days 
Temperature 37ºC 29ºC 25-37ºC 18-29ºC 15-25ºC 
Immunity 
Innate Yes Yes Yes Yes Yes 
Adaptive Yes Yes No No No 
Biological relevance Confirmed Confirmed Potential Potential Potential 
Ethical considerations Yes Yes No No No 
 
Rodent models became an election model to study lung infections caused by P.aeruginosa. One of the 
first models to be used was the rat model. In 1979, Cash inserted P. aeruginosa embedded in agar beads into 
the host rat, the mediation of agar beads or either agarose beads is essential to start the respiratory infection 
given the propriety of retaining physically the bacteria on the respiratory tracts and thus mimicking the bacterial 
biofilm present in airways tract infections such in the patients with cystic fibrosis [114]. Now it is evident that P. 
aeruginosa embedded in agar beads is more representative of the lung infection, although administration of the 
free-living bacteria cells may also reproduce relevant proceedings of a respiratory infection [112]. This procedure 
of agar bead model was then adapted for a new model using mice. Mice were modified genetically to simulating 
situations of fragile host system with susceptible respiratory functioning, such as in CF patients.  
Other mammal models have been used for studies on respiratory tract infections and virulence potential 
caused by P. aeruginosa, given their lung size, architecture and function, more similar to the human. Ferrets 
have been used to test whether P. aeruginosa alginate stimulates secretion from mucous or serous cells in its 
trachea. Cat models was also used to study pulmonary infection using P. aeruginosa embedded in agar beads, 
the inflammation scenario in cat is very similar to the human case [112]. 
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Even though the mammal model represent a valuable host model for human infection disease, there 
are several drawbacks in using this model that extends from ethical, social and scientific viewpoints to cost-
effectiveness of the experiment. Many countries have tight regulations about animal experiments, leading many 
times to preclude the designated research. Also, the success of the usage of these models depends of a proper 
training of the staff, suitable experimental facilities and rigorous justification of the work. The animal species 
must be available, and ideally bred specifically for the infection research purpose, ensuring that the using model 
is free from pathogens which might be found in wild animals. Furthermore, despite of mammals being a finest 
host model, it is important to note that some mammalian used species may lack some of the human molecular 
features, such as cell surface receptors. These disadvantages of the mammalian host models led researchers 
to reduce, refine and replace these models for non-mammalian host model alternatives [113]. 
Non-mammalian host models represents many practical advantages over the mammal models, given 
the size of the models, cost-effectiveness, easy prolific reproduction, space confinement and maintenance [113]. 
One of the most well-established model of vertebrate cellular and genetic development in use is the 
Zebrafish (Danio rerio). This non-mammalian model combines the advantages of both invertebrate and rodent 
model, since this fish have about 6.4 cm in size and is relatively easy to handle and possesses both innate and 
adaptive immune systems. Zebrafish has been used as a model for P. aeruginosa infection, which was able to 
cause lethal infections in zebrafish embryos, influenced by inoculum size, presence of virulence determinants, 
the development stage of the zebrafish embryos, and the presence of immune cells [115]. Some of the main 
drawbacks of this model, may constitute the zebrafish inability to survive at 37ºC, thus temperature regulated 
genes don’t induce infection, the likelihood of zebrafish do not possess mammalian target receptors or organ, 
and zebrafish may not exhibit a complete immune response [113].  
Insect models such as Drosophila melanogaster and Galleria mellonella have been chosen as fine 
models for infection mechanisms given its easy handling, maintenance and low cost. Insects have an innate 
immune system comprising cellular and humoral responses. Cellular response in insects involves production 
and mobilization of haemocytes that engulf bacteria, and the humoral response consists in the activation of Toll 
and Imd pathways ultimately leading to the expression of antimicrobial peptide genes [113]. 
Drosophila melanogaster is a fruit fly with an innate immune system that protects it from wide range of 
infections, in a multiple microorganism interaction environment through its lifetime. Intensive investigation has 
been conducted under the signal transduction cascade intrinsic to this system and these studies have revealed 
prominent resemblances to the mammalian innate immune response. Thus, this insect model is regarded as a 
good model organism to study complex interactions between P. aeruginosa virulence factors and host defenses 
motivated by human illnesses like pulmonary diseases [116]. One of the drawbacks of D. melanogaster as host 
model for study of human infectious diseases is the temperature of the infection assays (20 - 30ºC) which is an 
obstacle to the study of temperature regulated virulence genes [113]. 
33 
The greater wax moth, Galleria mellonella, has been a significant model to study human-pathogen 
interactions. The potential to explore aspects of mammalian innate immunity in the insect larvae combined with 
its low cost, easy maintenance and ethical acceptability, fixed G. mellonella larvae as an establish model. Many 
pathogens have been tested in this model, including the study of P. aeruginosa infection mechanism and their 
virulence factor mode of action such as the type III secretion system (TTSS) [117]. A great advantage compared 
to the D. melanogaster model and other invertebrate models is the fact that G. mellonella larvae grow at 37ºC, 
thus enabling the study of temperature regulated virulence genes [113], [115]. 
Other well studied non-mammalian model is Caenorhabditis elegans. This organism is a bacteria-feeding 
nematode that lives in soil and can occasionally encounter P. aeruginosa in a host-pathogen skirmish in their 
own environment [118]. This nematode model is easily maintained in laboratory on agar plates, previously 
seeded with bacteria, such as Escherichia coli or Bacillus subtilis, have a rapid generation time, and, possesses 
an innate immune system that shows similarities with the mammal innate immune system [113], [115]. 
Concerning the C. elegans defense pathways, there is still a lack of knowledge about how it fights pathogenic 
microorganisms. It is also not well understood if C. elegans has an innate immune response similar to other 
models like insect and mammalian models [118]. Moreover, this model presents, also, as a disadvantage, 
several different development stages, including larval stages which may respond differently to different types of 
infection [113].  
Plant models have been recently used as a reliable non-vertebrate host alternative of a human bacterial 
pathogen, much due to their Toll-like receptors, useful for analysis like in vivo high throughput screenings for 
virulence factors involved in mammalian pathogenesis [113], [115]. Virulence factors that play roles in animal 
diseases have been demonstrated to also play roles in plant diseases. Furthermore, some bacterial pathogens 
have evolved to cause disease both in mammalian and plants hosts [113]. 
Plant models have been used to bring more understanding about the infection mechanisms of P. 
aeruginosa. Pioneering studies on plant infection models have used clinical isolates of P. aeruginosa. It was 
demonstrated that human clinical isolates of P. aeruginosa were infectious in Arabidopsis thaliana model [113], 
[119]. Also, human clinical isolates were capable of causing soft-rot in plants like onion, tomato, lettuce and 
tobacco [120]. 
Pseudomonas aeruginosa utilizes a common set of virulence factors to infect both animals and plants 
pointing for a conserved universal mechanisms of pathogenesis through divergent evolutionary lines, ultimately 
leading to the usage of genetically tractable model hosts such plant models in development of therapeutics 
[119], [121]. 
Using plant models represents many advantages such as the cost-effectiveness of easily growing and 
handling the host and the high capacity of screening numerous bacterial strains in short time [121]. Although, 
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size and growth differences between individuals, and significant differences in the pathogenic potential of 
bacterial pathogens, such as P. aeruginosa, towards plants, constitutes major disadvantages of this host model. 
These host models presented above represent whole systems models that provide the most information, 
but such models are unsuitable for more specialized analysis of bacterial virulence mechanisms [113]. 
1.4.1.1 Cell lines host models 
Mammalian cell lines have shown a wide range of applications for numerous cellular function, 
morphological responses and pathogenicity studies. Robust and representative models of human cells and 
tissues are a pivotal for the interrogation of host-pathogen interaction. Cell line cultures represents a cost 
effective and a high-throughput experimental system which facilitates the dissection of pathogen interaction with 
a single cell type [113]. 
Cultured mammalian cells used for host-pathogen interaction studies comprise primary cells derived 
from a host, such as bone marrow-derived macrophages. Generally, these primary cells have a short life span, 
although they may be more representative of an in vivo response. Immortalized cell lines are also used for host-
pathogen interaction studies, this type of cells proliferate indefinitely through random mutation or genetic 
modification. Different immortalized cell lines have advantages and disadvantages regarding their relevance and 
use as an infection model. For instance, these cell lines represent mammalian phagocytes cells, such as murine 
macrophage-like cell lines RAW264.1 and J774A.1, or human monocyte cell line THP-1. Furthermore, 
immortalized cell lines such as the monkey-derived COS-1 and the canine-derived MDCK are easily handled and 
they are promptly transfected for certain host-interaction studies, but, these cell lines may be less physiologically 
relevant to clinical infection than Hep-2 and HeLa cells. In the other hand, human cell lines such as the human 
colon epithelial T84 and CaCo2 cells are difficult to handle and to transfect, but, they are derived from human 
tissue and may be more physiological relevant for analysis of gastrointestinal pathogens that break through the 
gut wall [113], [122]. 
The monitoring of interactions between bacteria and culture cells have recurred mostly to three main 
approaches. The first approach comprise imaging the host-pathogen interactions using a range of microscopy 
methods. When cells are grown in an optical accessible surface it is possible to analyze specific interaction of 
the pathogen with the single cell type, such as cellular rearrangements. The imaging approach has been central 
to understanding of infection mechanisms of several pathogens. The second approach relies in measuring the 
host-pathogenic interaction by enumeration of bacteria stacks following a host-pathogen experiment designed 
to answer a specific question, such as, quantification of bacteria that have invaded or adhered to a cell 
monolayer, or quantification of bacteria that have survived within a macrophage monolayer. This type of 
approach is advantageous for studying the genetic basis of infection mechanisms, such as adhesion, invasion 
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and intracellular survival. The third approach involve analyzing inflammatory response driven by host-pathogen 
interaction, measuring cytokine and chemokine secretion profiles [113]. 
Thus far, cell culture-based infection models have been an election model to study P. aeruginosa 
cytotoxicity, for identifying important virulence factors and examine interactions with the epithelial barrier. The 
cell lines usually chosen to verify the pathogenicity of the P. aeruginosa are related with the tissues and organs 
that these bacteria typically infect, mostly regarding some cellular restraint given the cells susceptibility to the 
opportunistic feature of the P. aeruginosa [113], [115], [123]. 
A number of cell lines have been used to study the infection mechanisms of P. aeruginosa, such as, the 
human lung carcinoma A549 cell line, used to study effects of virulence factors, adhesion and invasion of 
respiratory tract cells, as also, alterations in gene expression in the host cell [115], [124], the CaCo-2 intestinal 
epithelial cells for studying P. aeruginosa interaction with the gastrointestinal tract [115], [125], the L929 mouse 
fibroblast, used in cytotoxicity assays and virulence factors processing studies [126], [127]. Also, the HeLa 
cervix epithelial cells [128], the MDCK canine kidney epithelial cells [129] and the CHO rodent ovary epithelial 
cells [130] and other cell lines have been used to study the host-pathogen interaction of P. aeruginosa [123].  
Despite of the suitability of cell line host models for studying bacterial virulence mechanisms, major 
drawbacks of these models should be taken in account, such as, the lack of differentiation in phenotypes and 
absence of the complexity of intact organs, as well, the fact that hypothesis about host-pathogen interactions 
studied in this reductionist model should be verified in a whole system in order to validate the data in the context 
of infection [113], [115].  
However, cell line host models maintain as a common choice for studying infection mechanisms due 
to their easier handling, cost-effectiveness, a more controlled condition status, the reaching of a more direct and 
objective study by specific conditions, observation of morphological changes at cellular level and the 
achievement of reproducible results [131]. Therefore, a cell culture-based infection system turn out to be the 
ideal model for evaluation of the pathogenic potential of P. aeruginosa strains, HB13 and HB15, in this thesis 
work[115], [132]–[135]. 
1.4.1.1.1 L929 and A549 cell lines  
Given the wide range of tissues and organs that P. aeruginosa can infect, several types of cell lines can 
be used as models to give relevant data and understanding about P. aeruginosa infection mechanisms. The 
frequent cell lines used are derived from respiratory tracts, urinary tracts, cancer, skin and blood from 
mammalian animals [122]–[130], [136], [137]. In this thesis work it was chosen the fibroblast mouse L929 
cell line and the lung carcinoma A549 cell line.  
The cell line L929 are fibroblasts derived from the subcutaneous connective tissue of mice (Figure 14). 
This cell line is derivative from strain L of a NCTC 929 clone, from line CCL-1, a commercial source from ATCC 
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[138]. Fibroblasts are commonly defined as collagen producing cells and have a major role in production of the 
most extracellular matrix components. Characteristically they have the capacity to differentiate in specialized 
cells that possess a contractile phenotype with a-smooth muscle actin expression, called myofibroblasts. They 
have an important role in wound healing generating contractile forces that allow wound closure. Beyond the 
capacity of differentiation in myoblast, other differentiations into different lineages have been shown [139]. 
 
Figure 14 – L929 cells. Contrast phase microscope shot of L929 cell culture grown in 96 well plate at 24h endpoint. The image 
show abundant distinguishable fibroblasts with spindle and stellate shape. The scale bar is set for 200 µm.  
This cell line is broadly used in several experimental procedures, from cell-to-cell interactions and cell-
matrix interactions studies, to cytotoxic assays, cell death mechanistic studies and bacterial virulence studies 
[140]–[143]. 
L929 cell line was used earlier in P. aeruginosa to determine its pathogenicity and effects of singular 
virulence factors. Since skin wounds are a vehicle for most bacteria invasions including P. aeruginosa we take 
advantage of this host tissue susceptibility which make L929 a good model to study infection mechanisms of 
this pathogen [127], [144]. 
The A549 cell line is composed of adenocarcinoma cells from basal epithelia of the human lung alveoli 
(Figure 15). This cell line is hypotriploid with a modal chromosome number of 66 occurring in 24% of the cells, 
other modal chromosome numbers, 64 and 67, are also relatively common [145]. This cell line was first 
identified by Giard et al., in 1972, through lung carcinomatous tissues explant culture from a Caucasian male 
58 years old patient [146]. Attending its morphology, these cells present a squamous shape and are organized 
as an adherent monolayer in vivo. Analysis of antigen expression revealed that this cell line is positive for keratin 
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by immunoperoxidase staining. Metabolically, these cells produce lecithin and also showed high levels of 
unsaturated fatty acids essential for the phospholipid cell layer maintenance [145]. 
The A549 cell line is commonly exploited as a fine in vitro model of type II lung epithelial cells as 
transfection host and for analysis of drug metabolism [147].  
 
Figure 15 - A549 cells. Contrast phase microscope shot of A549 cell culture grown in 96 well plate at 24h endpoint. The image 
show abundant distinguishable fibroblasts with spindle and stellate shape. The scale bar is set for 200 µm. 
Nowadays this cell line is widely used for diverse research concerning the pulmonary locus, homeostasis 
and function. It is suitable for studies of cellular processes related to the synthesis and secretion of saturated 
phosphatidylcoline [148]. Several studies has been performed with P. aeruginosa using the A549 cell line, 
analyzing cellular responses to the virulence factors, cellular apoptosis, oxidative stress, cellular adhesion, 
cytotoxicity, gene regulation and others [124], [149]–[153]. 
The characteristics and the former records of these two cell lines made them a suitable study model for 
the subsequent pathogenic studies in the P. aeruginosa strains, HB13 and HB15.  
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1.5. Objectives 
This thesis work was conceived in the Laboratory of Molecular Biotechnology, the Laboratory of Animal 
Cells, and the Laboratory of Culture of Animal cells at the Molecular and Environment Biology Centre / 
Department of Biology of University of Minho, under supervision of Prof. Andreia Gomes, Prof. Pedro Miguel 
Santos and Prof. Isabel Alcobia (Faculdade de Medicina de Lisboa). It was performed in the scope of the of the 
2nd year of the Master Degree in Applied Biochemistry in the specialisation area of Biomedicine, of the 
Department of Biology of University of Minho, and it aimed for the following main tasks: 
a) Performance of an initial screening of secreted virulence factors of the two clinical isolates, with 
different pathogenic features, obtained from Hospital of Braga’s patients’ sputum, classified later 
as P. aeruginosa strains HB13 and HB15, alongside with the PAO1 reference strain, in two different 
animal cell lines, L929 and A549.   
b) Characterization of the subsequent cytotoxicity of the PAO1, HB13 and HB15 strains on L929 and 
A549 cell lines.  
c) Characterization of the morphological alterations and oxidative stress induced by the P. aeruginosa 
strains, PAO1, HB13 and HB15, in the animal cell lines, L929 and A549.  
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2.1. Biological Material 
2.1.1. Bacterial species and strains 
The bacterial species used in this thesis project was P. aeruginosa. In the context of a partnership 
between CBMA-UM and the Hospital of Braga, two different clinical isolates from the sputum of the patients 
infected with P. aeruginosa, classified as HB13 and HB15 [94], were available for this study. The strain HB13 
does not produce pigments and evidenced resistance to a wide range of antibiotics. On the other hand, the 
strain HB15 produces a significant quantity of pyocianin pigments and it is susceptible to antibiotics [94]. The 
P. aeruginosa strain PAO1 was used in this thesis work as a reference strain, as its genome is fully sequenced, 
extensively documented and is frequently studied in the scientific environment [19]. The strains used in this 
thesis work are identified in Table 5. 
Table 5 - List of bacteria strains used in this thesis work. 
Strain Information Reference 
Pseudomonas aeruginosa HB13 Pan-resistant clinical isolate [94] 
Pseudomonas aeruginosa HB15 Susceptible clinical isolate [94] 
Pseudomonas aeruginosa PAO1 All sequenced reference strain [19] 
2.1.2. Bacterial culture media 
The bacteria strains were cultivated in both liquid and solid medium (2% Agar medium supplement) of 
Lysogeny Broth (LB), with the Lennox formulation (LB-Lennox) composed with: 0.5% (w/v) Yeast extract, 1% 
(w/v) Tryptone and 0.5% (w/v) NaCl.  
2.1.3. Animal cell lines maintenance 
Two cell lines were used in this work in order to perform the studies of pathogenic potential of 
Pseudomonas aeruginosa: 1) L929 cell line, which are fibroblasts derived from the subcutaneous connective 
tissue from mice (Mus musculus). This cell line is a derivative from strain L of a NCTC 929 clone, from line 
CCL-1, commercially available from ATCC [154]. 2) A549 cell line, adenocarcinomic human alveolar basal 
epithelial cells with a triploid chromosomal feature. This cell line was initiated in 1972 by D.J. Giard, et al., 
[155], through explant culture of lung carcinomatous tissues from 58-year-old Caucasian male [155].  Both 
L929 and A549 cells are adherent cells (Table 6). 
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Table 6 - Generic properties of the animal cell lines used in this work thesis. 
Cell Line L929 A549 
Cell morphology Fibroblast Epithelial 
Cell culture properties Adherent Adherent 
Derivative tissue Skin connective tissue Lung 
Species Mus musculus Homo sapiens 
Age 100 days 58 years 
Gender Male Male 
Disease condition  None Carcinoma 
2.1.4. Animal cell culture media 
The animal cell cultures were both cultivated with Dulbecco Modified Eagle’s Medium (DMEM) with 
different formulations as shown in Table 7. 
Table 7 - L929 and A549 cell culture medium formulation. 
L929 cell culture medium A549 cell culture medium 
1.34% (w/v) DMEM (DMEM high glucose, Sigma-
Aldrich “D5648” 
1.34% (w/v) DMEM (DMEM high glucose, Sigma-
Aldrich “D5648” 
0.477% (w/v) HEPES - 
0.15% (w/v) NaHCO3 0.37% (w/v) NaHCO3 
10% (v/v) FBS 10% (v/v) FBS 
1% (v/v) L-glutamine 200mM. 1% (v/v) L-glutamine 200mM 
1% (v/v) Pre-set antibiotic mix: penicillin, 
streptomycin and amphotericin B 
1% (v/v) Pre-set antibiotic mix: penicillin, streptomycin 
and amphotericin B 
0.002% (v/v) Puromycin 0.002% (v/v) Puromycin 
pH range: 7.2 – 7.4 pH range: 7.2 – 7.4 
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2.2. Pseudomonas aeruginosa virulence factors 
2.2.1. Growth conditions of Pseudomonas aeruginosa strains 
In order to obtain the virulence factors to be produced and secreted by Pseudomonas aeruginosa 
strains, bacterial culture growths were performed with two different time points of extraction. 
The three Pseudomonas aeruginosa strains were cultivated in LB-Agar petri dishes and let to grow 8 
hours at 37˚C. The cultures were then refreshed in new LB-Agar and grown overnight at room temperature. 
An isolated colony forming-unit (CFU) was obtained from solid cultures and used to perform a pre-
inoculum in liquid LB medium overnight at 37˚C. The optical densities (OD) of the pre-inoculi were measured 
at 600nm wavelength and an inoculi for the three strains were performed with a starting OD of 0.08. All the OD 
measures were performed with the equipment Genesys 20 Thermo Spectronic. Both pre-inoculi and inoculi 
liquid bacterial cultures were incubated at 37˚C with orbital shaking (200rpm) in an incubator Novotron HT 
Infors AG CH-4103 BOTT MINGEN. 
The inoculi were grown for 24 hours and 48 hours to each strain at the pre-set conditions described 
above.  
2.2.2. Bacterial culture supernatants extraction 
After 24 hours or 48 hours of bacterial growth in LB liquid medium, the OD’s were measured and the 
cultures submitted to a centrifugation at 11,000 rpm, during 10 minutes at 4˚C with an Eppendorf Centrifuge 
5804 R. 
The cultures supernatants were then extracted, filtered with a 0.22 µm filter and aliquoted. The total 
protein content of the supernatants was then quantified as described in the following section. The aliquots were 
kept at -80˚C until further use. 
2.2.3. Total protein quantification 
A fraction of the filtered Pseudomonas aeruginosa strains culture supernatants was used for the total 
protein quantification. The modified Lowry method was used for the quantifications. A BSA concentration 
gradient was used to obtain a calibration curve. The total protein concentration of the supernatants was then 
obtain by extrapolation of the calibration curve. 
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2.3. Virulence studies 
2.3.1. Pseudomonas aeruginosa virulent factors testing concentrations 
A gradient of 7 concentrations from the quantified total protein of Pseudomonas aeruginosa strains 
culture supernatants obtained at 24 and 48 hours of growth were set for the virulence potential studies. 
The concentration gradient started from the settled initial total protein concentration of 20.50 µg/ml and then 
6 sequential dilutions, with a dilution factor of 6x, were performed according the follow table (Table 8). 
Table 8 – Table of supernatant culture protein concentration gradient. 
2.3.2. pH tests 
Preparation of the gradient concentrations of total protein of Pseudomonas aeruginosa strains culture 
supernatants were set for pH measurement. Also, the initial concentrations of culture supernatants and bacterial 
culture medium LB was prepared for similar measurements. 
The prepared samples were measured with a digital pHmeter, pHMeter pH 538 MultiCal ® WTW. The 
obtained pH values were annotated. 
2.3.3. Cell lines growth conditions 
The L929 and A549 cell lines were thawed and maintained growing in 4ml of the respective culture 
medium in a T25 flask at 37˚C and 5% CO2 in a CO2 incubator BINDER.  
After reaching a confluence of 90%, the L929 cells are sub-cultivated to a new T25 flask with a starting 
cell density of 30,000 cells/ml. For the same condition, the A549 cells are sub-cultured to a new T25 flask with 
a starting cell density of 55,000 cells/ml. All procedures with animal cells lines were performed in sterile 
conditions in a laminar flux chamber (Telstar BIO IIA nº594). 
2.3.4. Cytotoxicity tests 
The cytotoxicity tests were achieved using MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium 
bromide) assay. The L929 and A549 cells were seeded in 96 well plates (TTP® tissue culture plates) 12 – 16 
hours before performing the assay itself. 
The cells were left to grow until reaching 90% confluence. After removal of the culture medium and 
wash with sterile PBS 1x, cells were detached from the culture flask with 0.05% (v/v) Trypsin:EDTA for 5 minutes 
at 37˚C.  
Concentration 
C1 C2 C3 C4 C5 C6 C7 
20.50 µg/ml 3.42 µg/ml 0.57 µg/ml 0.09 µg/ml 0.02 µg/ml 1.00x10⁻3 µg/ml 1.00x10⁻4 µg/ml 
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Fresh cell culture medium was added in order to inactivate the trypsin. The cell count for the suspension 
was performed with a Neubauer chamber.  
For each experiment, the L929 cell suspension was added to each well of a 96 well plate in a total 
volume of 100µl with cell density of 55,000 cells/ml. For the A549 cells, 100µl of cell suspension was added 
to each well with a density of 100,000 cells/ml. 
The culture plates of L929 and A549 were let grow 24 hours at 37˚C and 5% CO2 with a BINDER 
incubator. 
2.3.4.1. Incubations with virulent factors 
After 24h of growth, the L929 cells, seeded in 96 well culture plates, were incubated with 50µl of the 
different concentrations of the Pseudomonas aeruginosa strains culture supernatants. Based on the results 
obtained with the L929 cell line, four concentrations were selected to incubate the A549 cell line 96 well culture 
plates, with the same procedure. The control set include a negative (-) control (only with cell line culture 
medium), a positive (+) control (containing 30% (v/v) DMSO) and bacterial culture medium (25% (v/v) LB and 
7.5% (v/v) LB).  
The incubations timepoints were defined for 24, 48 and 72 hours. 
2.3.4.2. MTT assay 
The MTT assay is a colourimetric assay that measures the cellular metabolic activity via NAD(P)H-
dependent cellular oxidoreductases enzymes that reduce the MTT to purple formazan, reflecting the number of 
viable cells (Mosmann 1983; Berridge et al., 2005). The cytotoxicity was obtained as percentage viability and 
calculated using the following formula: 
 
% Viability = 
A(570nm) of the culture incubated with supernatant 
A(570nm) of the control culture
 × 100 
 
The MTT assay was performed in 96 well culture plates after the referred incubation periods. After 
culture medium removal, cells were incubated with 100mM of MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-
diphenyltetrazolium bromide), dissolved in PBS 1x, for 90 minutes at 37˚C and 5% CO2.  
The resulting formazan crystals were dissolved with 200 µl of DMSO:Ethanol (1:1) solution. After 
dissolution, the absorbance of the formazan compound was read at 570 nm in a plate reader Molecular Devices 
Spectra Max Plus 384. 
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2.3.5. Cellular morphology observations 
Cellular morphology alterations induced by the culture supernatants of the Pseudomonas aeruginosa 
strains were investigated by optical and fluorescence microscopy using an inverted microscope Olympus IX71 
58F-3, equipped with a Olympus DP72 camera and fluorescent exciter X-Cite series 120Q EXFO.  
In optical microscopy, cells were visualized directly in the 96 well plates destined to the MTT assay. In 
fluorescence microscopy, cells were visualized on coverslips from 24 well culture plate. 
2.3.5.1. Sample preparation for fluorescence microscopy 
In order to visualize cells by fluorescence microscopy, cells were grown in coverslips inside 24 well 
plates after preparation as described earlier.  
The L929 cell suspension was added to each well in a total volume of 500µl with a density of 61,000 
cells/ml. For the A549 cells, 500µl of cell suspension were added to each well with a density of 111,000 
cells/ml. 
2.3.5.2. Incubation with virulent factors 
The L929 and A549 cell lines seeded in 24 well culture plates were incubated for 24 hours with 2 
selected gradient total protein concentrations, 3.42 µg/ml and 0.0026 µg/ml, of the Pseudomonas aeruginosa 
strains culture supernatants from 24h and 48h of bacterial growth. The control set comprehends a life control, 
a death control (incubation with 30% DMSO) and culture medium control (incubation with 25% of LB medium). 
2.3.5.3. Cytoskeleton and nucleus staining 
After incubation, the cells were fixed with 3.7% formaldehyde solution for 10 minutes at room 
temperature. 
The cells were then permeabilizated with 0.1% Triton X-100 solution for 5 minutes. 
Cytoskeleton actin was stained with Phalloidin linked to a fluorescent probe Alexa® Fluor 568(life 
Techologies) during 2 hours at room temperature. 
Nucleus DNA was stained with a bis-benzimide (2`-[4-ethoxyphenyl]-5-[4-methyl-1-piperazinyl]-2,5`-bi-
1H-benzimidazole trihydrochloride trihydrate) die, Hoechst 34580 (lifeTechologies) for 30 minutes at room 
temperature. 
47 
2.3.6. Oxidative stress tests 
2.3.6.1. Sample preparation 
The L929 cell suspension was added to each well in 24 well plates in a total volume of 500 µl with cell 
density of 61,000 cells/ml. For the A549 cells, 500 µl of cell suspension was added to each well with cell 
density of 111,000 cells/ml. Cultures were maintained in standard culture conditions for 24h to stabilize prior 
to incubation with virulence factors. 
2.3.6.2. Incubation with virulent factors 
The cell lines seeded in 24 well culture plates were incubated for 1 and 4 hours with 2 selected total 
protein concentrations from Pseudomonas aeruginosa strains culture supernatants. The control set was 
performed similarly to the control sets in the preceding tests with a hydrogen peroxide control (2mM H2O2).  
2.3.6.3. DCF assay 
After incubation with the Pseudomonas aeruginosa strains supernatant cells were loaded with 200µl of 
2’,7’ –dichlorofluorescein diacetate (DCFH-DA) 100mM and incubated at 37˚C and 5% CO2, in absence of light.  
The cells were later lysed with a solution of 90% DMSO – 10% PBS 1x.  
The lysate was transferred to a 96 well black plate and the fluorescence intensity read in a fluorimeter 
FLuoroskan Ascent FL (Thermo Scientific) using an excitation wavelength of 485nm and emission wavelength 
of 538nm. 
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2.4. Statistical Analysis 
All the experiments were repeated at least twice. Data were expressed as means with standard 
deviation for n independent experiments. A One way ANOVA analysis with post-hoc Tukey test was performed 
for multiple comparisons. A P-value of 0.05 was considered significant. GRAPHPAD PRISM 5 (GraphPad Soft - 
ware Inc., San Diego, CA) was used for the analysis. 
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3.1. Bacterial culture growth 
The Pseudomonas aeruginosa strains PAO1, HB13 and HB15 were grown in LB-Lennox medium for 24 
and 48 hours. For each strain and time point, the bacterial culture growths were prepared in duplicate. The OD 
of the respective bacterial cultures was measured at 600nm wavelength to assess the cell culture density. All 
the cultures started from an OD at 600nm of 0.08 (Table 9). 
After 48 hours of culture growth there was a marked decay of optical density comparably to the 24 
hours of culture growth. The accentuated reduction of optical density directly related with cell density is mainly 
due to the exhaustion of nutrients that happens through the decline phase of bacterial growth [158]. It is known 
that after 8 hours the bacterial growth of the reference strain (PAO1) reach a stationary phase with a constant 
OD>5 which indicates that the bacterial growth is already in a decline phase after 24 hours [159]. The selection 
of these two time setups of bacterial culture growth, was made in order to obtain a maximum of extracellular 
products, as also, verifying if through time there is any decadence of the secreted virulence factors. 
The PAO1 and HB15 strain cultures have a higher cell density than HB13 strain culture at 24 hours of 
growth, however, at the end of 48 hours the HB13 strain culture has a higher density of cells than the PAO1 
and HB15 strain. We can infer by the analysis of the results that PAO1 and HB15 strains have a higher growth 
rate which exhaust quicker the medium nutrients leading to a higher cell death at the end of 48h of bacterial 
growth, than the HB13. In the other hand the HB13 strain comparatively to the two strains above appears to 
have a lower growth rate because it shows a significant lower cell density after 24 hours and a higher cell density 
after 48h of bacterial growth. It is already reported that HB13 is a pan-resistant strain [94], and many studies 
point out that antibiotic resistant come with an effective biological fitness cost which is visible in these results 
[61], [160]–[162].  
The performance of these bacterial cultures were essential to obtain supernatants with appropriate 
quantities of secreted virulence factors. 
3.2. Virulence factors extraction 
In order to evaluate the pathogenicity of the Pseudomonas aeruginosa strains conferred by the secreted 
virulence factors, the supernatants were isolated from the respective bacterial cultures. The supernatant of the 
Pseudomonas aeruginosa strains is composed of the consumed LB-Lennox medium and the bacteria secreted 
products which includes the virulence factors. In this framework, the cultures supernatants are a plentiful niche 
of secreted virulence factors produces by the P. aeruginosa strains. The isolation of the supernatant was 
obtained by centrifugation of the bacteria cultures and subsequent filtration to eliminate the remaining bacteria 
cells and cells debris. 
52 
3.3. Protein quantification of the supernatants 
Total protein quantification was performed in order to assess the virulence factors secreted by the 
Pseudomonas aeruginosa strains. Since most of the secreted virulence factors are of protein nature [36], a 
protein quantification came out as a reliable method to estimate the amount of virulence factors. 
To assess the protein levels the modified Lowry method was used. A calibration curve was drawn using 
serial dilutions of bovine serum albumin (BSA), with the mathematical equation y = 0.0133x + 0.1119 where Y 
is the absorbance and X the amount of protein. The resulting Pearson coefficient of determination was found 
acceptable. 
Based on the calibration curve it was possible to determine the total protein concentration of the 
Pseudomonas aeruginosa strains supernatants showed in the table below (Table 9). 
Table 9 – Optical densities of the culture growth and total protein determinations of the culture supernatants from 
the Pseudomonas aeruginosa strains. The table shows the optical densities (OD) of 24h and 48h bacterial culture growth from 
P. aeruginosa strains, and the subsequent protein concentration from its culture supernatants. 
STRAIN 
Bacterial 
growth time 
Bacterial 
culture OD 
[Protein] µg/ml 
PAO1 
t1 = 24h 4.53 206 
t2 = 48h 1.15 310 
HB15 
t1 = 24h 3.91 164 
t2 = 48h 0.94 303 
HB13 
t1 = 24h 2.41 105 
t2 = 48h 1.79 158 
 
The HB15 strain culture supernatant has almost the same quantity of protein as PAO1. In contrast, the 
HB13 strain culture supernatant has much less protein than the PAO1 and HB15 strains (Table 9).  
The variation on the amounts of protein on the supernatants is related with pathogenic and metabolic 
features of each strain. Although each strain presented different amounts of protein, it is observable a noteworthy 
difference of protein quantity between the HB13 strain and the other two strains. We can relate this protein 
amount difference with the pathogenicity of the strains, it is already known that the HB13 is a lesser pathogenic 
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strain than the HB15 and PAO1, and that high pathogenic strains produce more extracellular proteins than low 
pathogenic strains [94], [163]. 
The assessment of the quantifications of the supernatant proteins were necessary for the subsequent 
pathogenic studies in this thesis work.  
3.4. pH measurements of the supernatants concentrations of the Pseudomonas 
aeruginosa strains 
The pH measures were made considering the protein concentrations from the 7 serial dilutions set of 
the supernatants from 24 and 48 hours (t1 and t2, respectively) of bacterial growth, in duplicate, of the 
Pseudomonas aeruginosa strains used for the cytotoxicity screenings and the original concentration where the 
supernatants were obtained. The pH of the LB medium and DMEM medium used for the P. aeruginosa was 
also measured. 
These measurements had as objective to verify if the pH of the chosen concentrations, and the media 
used, exhibited significant differences between each other which could lead to adulterated cytotoxicity results. 
The results shows that it was not found any significant pH difference between the supernatant dilution 
concentrations with each other, and with the media, discarding possible adulterations in the cytotoxicity tests.  
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3.5. Cytotoxicity tests 
Cytotoxicity is one of the main properties of pathogenic microorganisms that consists in the attribute of 
being toxic toward cells. The analysis of this property is a direct approach to study the Pseudomonas aeruginosa 
pathogenicity in the chosen cell models. The MTT assay was used in order to evaluate the cytotoxicity and 
consequent pathogenicity of the three Pseudomonas aeruginosa strains on the mammalian cell lines L929 and 
A549. 
The serial range of total protein concentrations previously established were used to evaluate the 
cytotoxicity of the culture supernatants from the Pseudomonas aeruginosa strains at three time points, 24, 48 
and 72 hours, of incubation with the mammalian cells. 
A control set was perform with a negative control, with cells grown only in its proper medium and a 
positive control, where cells were incubated with 30% of DMSO. 
Additionally to the negative and positive controls, two bacterial medium controls (7.5% and 25% of LB 
medium) were included. The purpose of these controls was to study the influence of the LB medium on the 
effective cytotoxicity caused by the secreted virulence factors. 
3.5.1. Cytotoxicity of culture supernatants of the Pseudomonas aeruginosa strains in the L929 
and A549 cell lines 
The first cytotoxicity tests were performed on L929 cells incubated with the culture supernatants. The 
L929 cell line is an easy handling, valid and robust model, widely used in a variety of biological tests, which was 
the fundamental reason for using it to initiate the screening of cytotoxicity of supernantants and define 
concentration range for further experiments.  
The L929 cells were incubated with two different type sets of culture supernatants concentrations of the 
P. aeruginosa strains. The sets represented the supernatants from two bacterial growth time points, t1 (24 hours) 
and t2 (48 hours). The utilization of these different timepoints was adequate to analyse the influence of different 
periods of bacterial growth on the associated cytotoxicity induced by the supernatants.  
The results showed that there are no significant differences in cytotoxicity levels caused by the 
supernatants obtained from 24 or 48 h of bacterial culture growth. Figure 16 shows the concentration which 
presented the highest variance (3.42 µg/ml). A standard tendency is noted in which the supernatants from t1 
cause more cellular toxicity than t2. These observations might indicate that, after 24 hours of bacterial growth, 
the associated cytotoxicity decreases. Although, statistically, the results are not significant.  
Other reports show that the secretion of several virulence factors is regulated in a growth-phase-
dependent manner in gram-negative bacteria [164]. In studies by Bernardo et al, in 2004, it was demonstrated 
that production of exoproteins, in the gram-negative bacterium Staphylococcus aureus, were regulated in a 
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growth-phase-dependent-manner occurring mostly in the post-exponential growth phase [165]. Posteriorly, 
Sturm et al., showed that the expression of the type three secretion system 3 (TTSS 3) in Salmonella 
typhimurium was increased in the beginning of the late logarithmic growth phase. Furthermore, at this growth 
phase, the increase of TTSS 3 expression would be related with growth-related environmental signals such as 
oxygen depletion, quorum signals, nutrient depletion and metabolites accumulation [166].  
In 2005, studies performed by Kim et al., showed that the P. aeruginosa type three system production 
was not active in the early adaptive-growth phase [167]. Anteriorly, it was already demonstrated that specific 
growth phases affected apoptosis induction and bacterial invasion ability in P. aeruginosa strains [168]. 
This previous knowledge of the influence of growth phases on the virulence mechanism in gram-negative 
bacteria, including P. aeruginosa, led us to search for visible effects on the associated cytotoxicity of the strains 
used in this work, between the two stipulated periods of growth. Based on that, in the above-described studies, 
the major influences of the growth phase were significant between exponential and stationary phase. In this 
work, the two selected timepoints already coincided with the death phase of P. aeruginosa culture growth. This 
might be the principal cause for the non-significant statistical results. Other timepoints from distinct bacterial 
growth phases, such as exponential and stationary growth phase, should have been selected in order to achieve 
significant results. 
 
Figure 16 – Comparison between cellular viabilities from two time points of bacterial growth of Pseudomonas 
aeruginosa culture supernatant in L929 cells. The graphic displays the comparison of the cellular viabilities results in L929 
cells from the MTT assay for each Pseudomonas aeruginosa strains (PAO1, HB15 and HB13) culture supernatants at the concentration 
3.42 µg/ml, in all the 3 end times of incubation (24h, 48h, 72), between the bacterial growth periods t1 (24 hours of bacterial growth) 
and t2 (48 hours of bacterial growth). The resulting data was statistically analysed by a One-way ANOVA with Tukey test where the P 
value was set for: P <0.05. Significant values comparing cellular viabilities between t1 and t2 were represented in the graphic as, * 
for P <0.05, ** for P <0.01 and *** for P <0.001. 
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The cytotoxicity of the P. aeruginosa strains supernatants was measured in cellular viability compared 
to the negative control where the fibroblast cells simply grew in their culture medium. 
In Figure 17 are shown the cellular viabilities for two concentrations of the supernatants used where the 
results were most significant. It is only shown the results from t1 supernatants, since there were no significant 
differences between the cellular viabilities of supernatants from the two time points of the bacterial growth. 
Results of all the serial concentrations tested in appendix (Figure A 2, Figure A 3, Figure A 4). The results showed 
an effective cytotoxicity of the P. aeruginosa strains affecting these cells. 
The strains led to different cellular viabilities, implying that they possess different cytotoxicity potential 
and therefore different pathogenicity.  
At the concentration of 3.42 µg/ml, the cellular viability was affected significantly in the PAO1 and the 
HB15 strains, in all timepoints of incubation considered. In the HB13 strain, the viability was affected 
significantly only after 72h of incubation with the supernatants. 
The strains from the clinical isolates studied here acted as expected, given previous evidences on their 
pathogenicity, in which the HB15 revealed a more aggressive infection potential than HB13. Previous studies 
performed by Soares-Castro et al. (2011) already indicated different levels of pathogenicity of these two strains. 
The HB15 demonstrated to possess unique genes that encode several virulence factors, contrary to the HB13 
strain. Furthermore, the production of bacterial pigments, characteristic of virulent strains, was found dissimilar 
between these strains, where the HB15 strain was able to produce large amounts of pyocyanin pigment while 
in the HB13 strain its production was absent [94]. 
In the results displayed in Figure 17, the HB15 strain caused significant cytotoxicity, even more 
pronounced than the reference PAO1 strain after 24 and 48 hours of incubation with the supernatants. On other 
hand, the HB13 strain caused minor cytotoxicity. Another analysis of the results showed that, after 48h of 
incubation with the supernatants, the cellular viability values associated to the three strains were more disparate, 
with 24% of cellular viability for HB15 strain, 36% of cellular viability for PAO1 strain and 70% of cellular viability 
for HB13. It is possible to fit this finding in a cytotoxicity level ranking where apparently the HB15 strain is the 
most cytotoxic strain, with less than 1.5 times PAO1’s cellular viability and almost less than 3 times HB13’s 
cellular viability. 
At the concentration of 20.50 µg/ml, six times the prior concentration, all strains severely affected 
cellular viability in L929 cells. 
The results were all strongly significant with some values of 10% of cellular viability in the PAO1 and the 
HB15 strains, which was lesser than the positive control viability values (30% DMSO). 
At this high concentration, the cytotoxicity variance between the strains was less prominent. Though, 
the HB15 strain apparently caused the highest cellular death compared with the other strains. And the HB13 
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strain despite of causing, in this concentration, significant cellular death, maintained itself as the less cytotoxic 
strain. 
 
 
Figure 17 - Cytotoxicity of the Pseudomonas aeruginosa strains culture supernatants on L929 cells. The graphic 
displays the results of the MTT assay performed on L929 cells submitted to two total protein concentrations (3.42 µg/ml and 20.50 
µg/ml) of the culture supernatants of the Pseudomonas aeruginosa strains (PAO1, HB15 and HB13) in cell viability percentage 
represented by bars with the respective standard deviation represented by vertical lines for a number of replicas n=2. The bar legend 
represents the end times of incubation (24h, 48h and 72h) with the supernatants. The full data is available in the appendix section of 
the thesis. The controls are presented in the graphic represented as “CONTROL”. The negative control has the constant value of 100% 
of viability for each end times of incubation and not shown in the graphic. The positive control is represented as “+” on the graphic. 
The controls of the bacterial culture media (LB) are represented on the graphic as “LB 25%” and “LB 7.5%”. The resulting data was 
statistically analysed by a One-way ANOVA with Tukey test where P value was set for: P <0.05. Significant values comparing to the 
negative control were represented in the graphic as, * for P <0.05, ** for P <0.01 and *** for P <0.001.  
 
In the control set, the negative control value was assumed as 100% of cellular viability in all periods of 
incubation, in the MTT assay.  
The positive control, as expected, caused high cellular toxicity in L929 cells. The DMSO used as control 
induces cell death by lethal membrane permeation [169], therefore its use was important to compare cytotoxicity 
levels associated to the supernatants.  
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The LB medium controls did not cause any significant effect on cellular viability. Therefore the LB 
medium present in the supernatants did not contribute significantly to the effective cytotoxicity of the secreted 
virulent factors in the supernatants.  
The LB medium controls were performed in two different concentrations (7.5% and 25%) in order to 
evaluate the dilution effect of the medium components. Although it was not significant, there was a higher 
disturbance in cellular viability (values between 70% and 80% (v/v)) with the highest concentration of LB medium 
(25% (v/v)). These results indicated that the LB medium proper components may interfere with cell viability 
when cells are exposed to the supernatants. In fact, the LB medium contains, aside of the yeast extracts and 
tryptone, considerable concentrations of salts (NaCl). This concentration of salt might be inducing an osmotic 
shock when the LB medium is added to the L929 cells, causing some cell death. It is shown in the literature 
that the effect of osmotic stress causing effective damage in animal cells [170].  
The cytotoxicity tests were continued on the A549 cell line. After the evaluation of the supernatants 
effect on L929 cells’ viability showing an effective cytotoxicity, it became relevant to analyse the cytotoxicity level 
induced with the supernatants in this different cell line model.  
The A549 cell line is a widely used in vitro model of pulmonary epithelia type II, responsible for the gas-
exchange in the respiratory system. Therefore, this cell line mimics one of the cellular tracts most affected by 
Pseudomonas aeruginosa infections, instigating the relevance of studying the effect of the supernatants on this 
cell line.  
As in the other cell line, the A549 cells were submitted to incubation with culture supernatants from two 
different timepoints of bacterial growth (t1 and t2). The analysis of the cellular viability results demonstrated that 
the supernatants from the timepoints of bacterial growth t1 and t2 caused similar cytotoxicity.  
In Figure 18, it was selected the concentration (3.42 µg/ml) where the cellular viabilities differences 
between the t1 and t2 were most noticeable. The results shown a tendency where the t1 supernatants induced 
more cellular death than the t2 supernatants, however not as perceptible as in L929 cells, and still not significant.  
The cytotoxicity of the P. aeruginosa strains supernatants on A549 cells was measured according as 
previous in L929 cells. 
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Figure 18 -- Comparison between cellular viabilities from two periods of bacterial growth of Pseudomonas 
aeruginosa culture supernatant in A549 cells. The graphic displays the comparison of the cellular viabilities results in A549 
cells from the MTT assay for each Pseudomonas aeruginosa strains (PAO1, HB15 and HB13) culture supernatants at the concentration 
3.42 µg/ml, in all the 3 end times of incubation (24h, 48h, 72), between the bacterial growth periods t1 (24 hours of bacterial growth) 
and t2 (48 hours of bacterial growth). The resulting data was statistically analysed by a One-way ANOVA with Tukey test where P value 
was set for: P <0.05. Significant values comparing cellular viabilities between t1 and t2 were represented in the graphic as, * for P 
<0.05, ** for P<0.01 and *** for P<0.001. 
 
In Figure 19 is shown that the cytotoxicity of the strains supernatants in cellular viability. The graphic 
shows the results for the two concentrations with the most significant results and give relevant information about 
the supernatant effect. Results of all the serial concentrations tested in appendix (Figure A 5, Figure A 6, Figure 
A 7). As before, it was only shown the results from t1 supernatants since there were no significant differences 
between the two timepoints of bacterial growth.  
At the concentration 3.42 µg/ml, the cytotoxicity of the supernatants demonstrated only significant 
effect on the A549 cells after 48h of incubation. In this situation, the HB13 strain was not able to produce any 
significant cellular death in all incubation times. The PAO1 strain and the HB15 strain supernatants led to similar 
cellular viability results.  
The cytotoxicity of the supernatants at the concentration 20.50 µg/ml showed a significantly higher 
percentage of cellular death comparatively to the previous concentration (3.42 µg/ml). As in the L929 cells, at 
this concentration the PAO1 and HB15 strains showed a strong significant effect in the cellular viability in all 
periods of incubation. Contrarily, the HB13 strain at this concentration only induced a strong significant effect 
on cellular viability after 72 h of incubation, and yet, its cellular viability (40%) remained superior to the highest 
cellular viabilities of the PAO1 and HB15 strains (30% and 25%, respectively). 
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These results showed that the HB13 strain causes minor cytotoxic strain as previously has been 
demonstrated, comparatively to the other strains. 
 
Figure 19 - Cytotoxicity of the Pseudomonas aeruginosa strains culture supernatants on A549 cells. The graphic 
displays the results of the MTT assay performed on A549 cells submitted to two total protein concentrations (3.42 µg/ml and 20.50 
µg/ml) of the culture supernatants of the Pseudomonas aeruginosa strains (PAO1, HB15 and HB13) in cell viability percentage 
represented by bars with the respective standard deviation represented by vertical lines for a number of replicas n=2. The bar legend 
represents the end times of incubation (24h, 48h and 72h) with the supernatants. The full data is available in the appendix section of 
the thesis. The controls are presented in the graphic represented as “CONTROL”. The negative control has the constant value of 100% 
of viability for each end times of incubation and not shown in the graphic. The positive control is represented as “+” on the graphic. 
The controls of the bacterial culture media (LB) are represented on the graphic as “LB 25%” and “LB 7.5%”. The resulting data was 
statistically analysed by a One-way ANOVA with Tukey test where P value was set for: P <0.05. Significant values comparing to the 
negative control were represented in the graphic as, * for P <0.05, ** for P <0.01 and *** for P <0.001.  
 
The control set was performed as previously and the results were similar as the obtained with the 
L929 cells as expected. This might indicate that A549 cells are more susceptible to DMSO than the L929 
cells.  
In all strains, the cellular viability presented high values comparatively to the previous results in L929 
cells. These results indicate that the two cell line models in study possess different susceptibilities to the 
associated virulence of the P. aeruginosa strains.  
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3.5.2. Comparison of cytotoxicity in L929 and A549 cell lines exposed to culture supernatants 
from the P. aeruginosa strains 
The cell lines used in this study displayed different susceptibilities to the associated cytotoxicity of the 
P. aeruginosa strains culture supernatants. In general, at the same concentrations, the supernatants cause 
more cytotoxicity in L929 cells than in the A549 cells. 
In Figure 20 are shown the supernatant concentrations where the cellular viability variance between 
L929 cells and A549 cells was most noticeable.  
 
Figure 20 – Cellular viability comparison of the L929 and A549 cell lines incubated with the supernatants from the 
Pseudomonas aeruginosa strains. The graphic displays the comparison of the cellular viabilities results of the MTT assays 
performed between the two cell lines L929 and A549 incubated with two concentrations (3.42 µg/ml and 20.50 µg/ml) of culture 
supernatants of the Pseudomonas aeruginosa strains where the viability variance between cell lines were highest. The cellular viabilities 
are represented for all end time points of incubation with the supernatants. The full data is available in the appendix of the thesis. The 
graphic bars represents the cellular viability percentage and the respective vertical lines represents the standard deviation, for a 
number of replicas n=2. The resulting data was statistically analysed by a One-way ANOVA with Tukey test where p value was set for: 
P <0.05. Significant values comparing cellular viabilities of L929 cells and A549 cells were represented in the graphic as, * for P 
<0.05, ** for P <0.01 and *** for P <0.001. 
 
The PAO1 and HB15 strains supernatants lead to highest cellular viability variances between the two 
cell lines at 3.42 µg/ml. At this concentration, with the HB15 strain, the highest significant variance value 
reached 40% of viability, after 48 h of incubation.  
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On the other hand, the HB13 strain has the highest viability variances between the two cell lines at 
20.50 µg/ml. At this concentration, the highest significant variance value reached 42% of viability, at 48 h of 
incubation.  
The concentrations where the cellular viability variance between the two cell lines were more noticeable 
appears to be related with the cytotoxicity level. Either too high or too low supernatant concentrations cause 
cellular viability results in a stage of plateau where the concentration effect is constant. Given that, the cellular 
viability comparison between cell lines is not suitable at these concentrations. Concentration where effect is 
strictly dependent of concentration, such concentrations are near to a half maximum death concentration, are 
more likely to produce relevant information about different susceptibilities of two cell lines. 
The appreciable cellular viability discrepancies between the two cell lines incubated with the 
supernatants demonstrate that these two cell models have different cellular features and mechanisms that 
provide more or less susceptibility to the virulence factors action which in consequence affect the cytotoxicity 
level. There is not, however, much information in literature about what molecular processes are responsible for 
the susceptibility level of the cell lines to the secreted virulence factors of the P. aeruginosa strains. 
The pathogenic characterization of the P. aeruginosa strains here performed based in the cytotoxicity 
tests revealed significant and expected rates of cell death in the cell models employed. In order to support these 
results, cellular damage and stress levels were assessed. 
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3.6. Morphology alteration studies 
The effects of bacterial pathogenicity at the cellular level can be analysed by direct microscopy 
observation. In the course of this thesis work, during the cytotoxicity tests, the cells incubated with the secreted 
virulence factors were firstly observed at the optical microscope in order to detect induced morphological 
alterations in the cells and/or evidences of apoptosis and necrosis, and therefore establish analytical 
associations with the results of the cytotoxicity tests.  
Secreted virulence factors from P. aeruginosa had been reported to induce morphologic alterations in 
cell lines. Virulent factors such as elastases (LasA and LasB) induced the tissue elastin destruction [171], 
alkaline protesases (AprA) induced damage on basal laminin [38], the TTSS system responsible for secretion of 
exoenzimes causing cytoskeleton actin alteration [40] also associated surfactants as rhamnolipids exhibited 
interference with cell-to-cell communication and disrupting cellular thigh junctions [43]. Cellular apoptosis 
induced by secreted virulence factors of the P. aeruginosa had been also reported in cell lines [172]–[177]. The 
exoenzyme ExoS secreted by T3SS caused the inhibition of the ERK1/2 and the p38 activation in HeLa cells, 
leading to the shutdown of the host cell survival signal pathways, subsequently leading to activation of 
proapoptotic pathways through elicitation of JNK1/2, and consequently lead to cytochrome c release and 
caspase activation [176]–[178]. The T3SS system had also been reported as an inducer of cellular apoptosis, 
not only by P. aeruginosa but also other several bacteria [174]. Pyocyanin produced by P. aeruginosa was also 
shown to induce apoptosis in neutrophils associated with consistent and swift generation of reactive oxygen 
intermediates and consequent reduction of intracellular cAMP [175]. Another cellular death form, necrosis, was 
verified in macrophages induced by P. aeruginosa secreted virulence factors such ExoU [174].  
These previous findings supported the need to search for evidences of morphological disorders in the 
cells incubated with the P. aeruginosa supernatants that could correlate with the cytotoxicity tests described 
previously. 
3.6.1. Cellular morphological changes in L929 cell line 
The L929 cell line, as previously described, are fibroblast murine cells with a spindle shape form, 
occasionally presenting a stellate form. These adherent cells are robust and proliferate well in proper conditions 
and media. As described in the methods of this work thesis, the L929 cells were seeded in 96 well plates at an 
initial density of 55,000 cells/ml in purpose of performing the cytotoxicity tests. All wells seeded with L929 at 
the initial density were let grown through 24 hours before starting the incubations with the P. aeruginosa strains 
supernatants that ended then at 24h, 48h and 72h.  
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It is observable that the L929 cells grow well and reached a state of confluence at the time of 48h of the 
end points of the incubations with the supernatants. Cell culture growth through time are displayed in the 
appendix (Figure A 8).  
The microscopy observations of L929 cells culture show the spindle and stellate shaped fibroblast cell 
population with presence of filopodia characteristic of the L929 cell line. It was also observable round shaped 
fibroblast cells, the emergence of this different shape dues to the entering of L929 cells in mitotic phase which 
confers round shape to the cell [179], [180]. 
The effect of P. aeruginosa virulence factors on these cells had induced noticeable morphological 
alterations at cellular level (Figure 21). All strains demonstrated to be able to cause morphologic disorders in 
the cells in a concentration- and time-dependent manner. Significant morphologic alterations in these cells were 
most noteworthy with the two highest concentrations (3.42 µg/ml and 20.50 µg/ml).  
Cell density appears to decrease in function of time and through concentration increase. The direct 
observation and analysis of the cells incubated with the P. aeruginosa strains supernatants suggests a 
correlation between cell density and the previous cytotoxicity data results, with lower cell density the lower 
cellular viability. Although, cell density alone cannot make a direct relation with cellular viability since cells could 
maintain its structural integrity but lost its cellular functions and so, its cellular viability [181].  
Aside cell density, significant cellular phenomena are observable in the cells incubated with the P. 
aeruginosa strains supernatants. One of the most noticeable morphological alterations in L929 cells incubated 
with the supernatants is the loss of its cellular spindle and stellate shape for a cellular round shape. All strains 
demonstrated to be able to cause cellular shape alteration, given that this feature is more distinct in the cells 
incubated with the strains PAO1 and HB15 (Figure 21), previously labelled has the most cytotoxic strains by the 
cytotoxicity tests results. The strain HB13, previously labelled as the less cytotoxic strain, was only capable of 
inducing a significant cellular shape alteration at the highest concentration after 72h of incubation (Figure 21). 
Although the presence of round shape L929 cells were referred above as cells that underwent mitosis in normal 
conditions, when incubated with the strains supernatants, the increasing appearance of round shape cells may 
be due to virulence factors of the strains, termed as cytopathic effect [182]. It was previously reported that HeLa 
cells under bacterial virulence factors lost their spindle shape to a round shape as also decrease the cell 
adherence [183]. Another study showed that L929 spindle cells underwent in a round shape after incubation 
with culture supernatant of Mycobaterium ulcerans. The alteration to a cellular round shape is attributed to the 
cytoskeleton rearrangement because of changes in the actin structure [182]. 
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Figure 21 - Morphologic alterations in L929 cells induced by Pseudomonas aeruginosa strains culture supernatants. 
The figure shows the L929 cells morphology alterations induced by Pseudomonas aeruginosa strains culture supernatants, cultured 
in 96 well plate, using phase contrast microscopy. The figure is divided in two sections, referring to morphologic alterations at 3.42 
µg/ml and 20.50 µg/ml. The images of the cells are displayed by incubation times (24, 48 and 72 hours) horizontally and by P. 
aeruginosa strain (PAO1, HB15 and HB13) vertically. The scale bars represents 100µm length. Cytotoxicity data from previous results 
are shown to make relation between cellular viability and cellular morphology observations. Data represents the means ± SD, n=2 
independent experiments. * for P <0.05, ** for P <0.01 and *** for P <0.001. 
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Moreover, P. aeruginosa has been reported as being able to induce cytopathic effect on cells [184], 
[185]. In a study by Zanetti et al., the multifactorial factor of the P. aeruginosa toxins in Hep-2 cells caused 
cytopathic effects [186]. Together with cell shape alteration, the cultured cells display agglutination clumps 
through the plate well surface, emerging in a time- and concentration-dependent manner of the strains 
supernatant. Above this feature, the more cytotoxic strains, PAO1 and HB15, are most noticeable. The L929 
cell distribution under the influence of the strains supernatant begin to form visible cell clumps after 48h of 
incubation with 3.42 µg/ml and after 24h of incubation with 20.50 µg/ml of HB15 supernatant (Figure 21). 
For the PAO1 strain, distinct cell clumps begin to be visible only after 72h of incubation with 3.42 µg/ml (Figure 
21). And for HB13 strain, there are no visible cell clumps at all times of incubation with 3.42 µg/ml, being only 
distinguishable after 72h of incubation with 20.50 µg/ml (Figure 21). Although there is not much information 
about cell agglutination caused by bacterial virulence factors, in particular with L929 cells and P. aeruginosa 
virulence factors, earlier observations have been described of cell clumps in animal cells caused by bacterial 
cell secreted products associated with apoptosis [187]. One of the most relevant morphologic alterations on the 
L929 cells induced by the supernatants of the P. aeruginosa strains observed by microscopy was cellular 
blebbing or zeiosis and formation of vesicles, much likely apoptotic bodies. Cell blebs are protuberances or 
bulges on the cytoplasmic membrane induced by localized disassembling of the cytoskeleton, associated to 
specific physiological functions including apoptosis [188], [189]. Apoptotic bodies are small vesicles derived 
from a cell undergoing in an apoptosis phase, frequently preceded by cell blebbing [190], [191]. Cellular vesicles 
were distinctly visible in the strains PAO1 and HB15 whereas in the strain HB13 presence of cellular vesicles is 
less distinguishable. In most cytotoxic strains, PAO1 and HB15, at the higher concentration after 48h of 
incubation, are visible isolated small vesicles, round cells presented abundant intracellular vesicles and blebs, 
and also cell lysis. These morphologic alterations are more accentuated in the HB15 strain, suggesting a more 
aggressive pathogenicity than its counterpart PAO1. After 72h of incubation, the majority of the cell were 
converted in small vesicles (apoptotic bodies) induced by HB15 strain whereas in the PAO1 there is still several 
cells with cytoplasmic membrane integrity. In the least cytotoxic strain, HB13, no significant formation of vesicles 
are observed with exception of the highest concentration (20.50 µg/ml) after 72h of incubation where traces of 
intracellular vesicle formation could be observed. Again it is observable for this morphologic alteration a time- 
and concentration-dependent relation, where the more the concentration and the time, the more is the cell 
blebbing and small cellular vesicles formation (apoptotic bodies). These observed morphologic alterations 
support the suggestion that these cells under influence of virulence factors of the P. aeruginosa strains 
underwent in apoptosis. It had already been previously stated the propensity of secreted virulence factors of P. 
aeruginosa to induce apoptosis in animal cells [174], [175]. Apoptotic features such as formation of apoptotic 
bodies has been reported in HeLa cells, and in other epithelia and fibroblast cells induced by P. aeruginosa 
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[178]. Furthermore has been reported formation of apoptotic bodies in endothelial cells induced by P. 
aeruginosa culture supernatants [192]. 
In order to enhance the observation of these morphologic changes at cellular level suggesting that L929 
cells underwent an apoptotic phase induced the culture supernatant of the P. aeruginosa strains, a fluorescence 
microscopy assay was conducted. 
The further microscopy fluorescence analysis of the intracellular morphological alterations of the L929 
cells induced by the P. aeruginosa strains focussed on changes of the cytoskeleton and nucleus of the cells. In 
order to achieve both cytoskeleton and nucleus structure image representation, each organelle was labelled with 
fluorescence stains. The L929 cytoskeleton was label with the commercial probe Phalloidin Alexa Fluor 568, a 
high affinity F-actin probe, constituted with a bicyclic heptapeptide toxin, Phalloidin, which interacts with actin 
filaments preventing its depolymerisation, and a red dye, Alexa Fluor 568 [193], [194]. On the other hand, the 
L929 nucleus was labeled with the commercial dye Hoechst 34580, a bisbenzimide blue dye that binds to the 
DNA double strand minor groove [195]. 
Given the previous results, it was selected a specific concentration and incubation time to apply the 
fluorescence microscopy to. All L929 cell cultures samples were let grown in 24-well plates for 24 hours. In the 
positive control, L929 cells were let grown incubated with only DMEM medium. In the L929 cells incubated with 
the P. aeruginosa strains supernatants, the cells were incubated with 3.42 µg/ml of supernatant from each P. 
aeruginosa strain. After incubation, the samples were transferred into cover slips for microscope observation 
(Figure 22).  
The obtained fluorescence microscopy images show distinct cytoskeleton and nucleus structures in all 
samples (Figure 22). In the control group, the cytoskeleton staining shows distinguishable actin filaments 
drawing the cellular shape. The L929 fusiform and stellate cell shape is also visible. The nucleus staining 
displays typical L929 uni-nucleated cells where the nucleus appears as a single integral organelle. In the samples 
of L929 cells incubated with P. aeruginosa strains supernatants morphological alterations iwere verified 
distinguishable. In the L929 cells incubated with 3.42 µg/ml of PAO1 strain supernatant it was verified cells 
developing cell blebs and nuclear fragmentation. In Figure 22 (PAO1), it is observable a cell exhibiting a bleb in 
its cytoplasmic domain traced by the phalloidin Alexa Fluor 568 stained cytoskeleton F-actin, pointed by white 
arrow. The cell blebbing phenomena observation at fluorescence microscopy with F-actin staining was been 
described, previously, as the emergence of the cellular bleb by initial F-actin rupture and hydrostatic pressure, 
the same F-actin promptly assemble at the bleb cortex, which became visible when using this technique [188]. 
In the same figure is visible a multi-nucleated cell with Hoechst 34580 stained six reduced nucleus indicating 
nuclear fragmentation. Nuclear fragmentation is one of the hallmarks of the apoptotic process [196], and it was 
previously reported in L929 cell line under virulence factors influence [197]. These findings, cell blebbing and 
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nuclear fragmentation, are in agreement with the above phase-contrast microscopy observations (Figure 21) 
and previous literature references, indicating that L929 cells enter an apoptotic phase. 
In the cells incubated with 3.42 µg/ml of HB15 strain supernatant, concrete apoptotic hallmarks as in 
the cells incubated with PAO1 strain supernatant (Figure 22), were not visible which was expected based on 
similar observations given previous results. The fact of the technique used for this fluorescence microscopy 
required many steps and double staining procedure might produce undesired results if mismanaged, which in 
this circumstance is causing the unreliable results. 
 
Figure 22 - Fluorescence microscopy of L929 cells to study morphological features induced by Pseudomonas 
aeruginosa strains. The cytoskeleton of the L929 cells are stained with the probe Phalloidin Alexa Fluor 568 (red) and the nucleus 
of the L929 cells are stained with the bisbenzimide dye Hoechst 34580 (blue). The merging of the individual stained components 
provides a composite image refining the cellular morphology observation. The L929 control cells cultured in DMEM medium, grown 
for 24h and transferred in cover slips for prior microscopy observation are represented as “Control ( – )”. The L929 cells incubated 
with the supernatants of the P. aeruginosa strains are represented as “PAO1”, “HB15” and “HB13”. All cells were incubated with 
3.42 µg/ml of P. aeruginosa strains supernatants during 24h, respectively and transferred in cover slips for prior microscopy 
observation. The white arrows points to noteworthy morphological features, in the up row (Phalloidin Alexa Fluor 568) indicates a 
visible cellular blebbing and in the middle row (Hoechst 34580) indicates a visible nuclear fragmentation. The scale bar represents 
25 µm length. 
In the cells incubated with 3.42 µg/ml of HB13 strain supernatant, there were no distinguishable 
noteworthy apoptotic hallmarks as in the PAO1 strain, which given the previous results, was expected because 
the HB13 strain was already classified as the less cytotoxic strain and L929 cells incubated at this concentration 
for 24 hours evidenced insignificant morphological alterations, furthermore presenting an high cellular viability 
(Figure 21). 
In an overall analysis of fluorescence microscopy applied to the L929 cells, it was availed determining 
cellular structures remarks that corroborate with previous results and the indication of Pseudomonas aeruginosa 
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strains inducing apoptosis. Although the results did not show an high quantity of these apoptotic cellular 
structures and the preliminary procedural mismanagements of this technique on the cells incubated with HB15 
strain supernatant avoided reliable results to use for strains effect comparison. Time and cost-effective limitation 
determined the use of a specific time/supernatant concentration (24h and 3.42 µg/ml) incubation of the cells, 
however, given the obtained results, using the higher concentration (20.50 µg/ml) of supernatant and the 
incubation times pre-defined previously (24h, 48h and 72h) would give an enhanced and more substantial 
results. 
3.6.2. Cellular morphological changes in A549 cell line 
Cellular morphological changes were analysed in A549 cells regarding the same microscopy procedure 
as in the analysis of cellular morphological changes in L929 cells. As already described, the A549 cell line are 
hypotriploid adenocarcinoma cells from basal epithelia of the human lung alveoli, these cells present a 
squamous shape and are organized as an adherent monolayer in vivo.  
A549 cells were seeded in 96 well plates at an initial density of 1,0x105 cells/ml with the purpose of 
performing the cytotoxicity tests, as previously described in the methods of this work thesis. All wells seeded 
with A549 at the initial density were let grown through 24 hours before starting the incubations with the P. 
aeruginosa strains supernatants that ended then at 24h, 48h and 72h.  
It is observable that the A549 cells grow well and reached a state of confluence at the time of 48h,  the 
end points of the incubations with the supernatants. Cell culture growth over time is displayed in appendix 
(Figure A 9).  
The microscopy observations made from the A549 cells culture grown with only the proper medium 
show the typical stellate shaped epithelial cells population cell. As in the L929 cell line culture, the presence of 
observable round shaped cells is due to the entering in mitotic phase of A549 cells which confers round shape 
to the cell [179], [198]. 
The A549 cells under the influence of the secreted virulence factors of the P. aeruginosa strains revealed 
significant morphological alterations at cellular level (Figure 23). 
As in L929 cells, all strains demonstrated to be able to cause morphologic disorders in a concentration- 
and time-dependent manner. Significant morphologic alterations in these cells were most noteworthy in the two 
highest concentrations (3.42 µg/ml and 20.50 µg/ml).  
As previously reported for L929 cells, one of the first morphological alterations observed in A549 cells 
incubated with P. aeruginosa virulent factors is the cell density decreasing in function of time and increasing 
concentration, which is one of the causes that lead to cellular unviability [181]. It is observable that there is a 
relation between cell density and cellular viability, while is observable in the Figure 23, that the least the cell 
density the least the cellular viability. 
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Figure 23 - Morphologic alterations in A549 cells induced by Pseudomonas aeruginosa strains culture supernatants. 
The figure shows the A549 cells morphology alterations induced by Pseudomonas aeruginosa strains culture supernatants, cultured 
in 96 well plate, using phase contrast microscopy. The figure is divided in two sections, referring to morphologic alterations at 3.42 
µg/ml and 20.50 µg/ml. The images of the cells are displayed by incubation times (24, 48 and 72 hours) horizontally and by P. 
aeruginosa strain (PAO1, HB15 and HB13) vertically. The scale bars represents 100µm length. Cytotoxicity data from previous results 
are shown to make relation between cellular viability and cellular morphology observations. Data represents the means ± SD, n=2 
independent experiments. * for P <0.05, ** for P <0.01 and *** for P <0.001. 
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One of the most noticeable morphological alterations in the A549 cells incubated with the P. aeruginosa 
supernatants is the change in cell shape and size. A general effect is observable with the virulent factors that 
cause A549 epithelial cellular shape to modify to a rounder shape and the independent appearance of some 
cells of odd size (Figure 23). 
These alterations are more noticeable in cell cultures exposed to the supernatants from the PAO1 and 
HB15 strains, increasingly evident with concentration increase and longer incubation time. In cell cultures 
incubated with HB13 strain supernatant, this feature is not so noticeable. In fact only with the highest 
concentration (20.50 µg/ml) and after 72h of incubation time, the cell culture displays significant morphological 
alterations in cell shape. Again, the HB13 strain is the least pathogenic strain and, as observed in the L929 
cells, it does not induce morphological alteration to the same extent as the other strains.  
Changes in the original A549 cell shape to a round form under the effect of virulence factors have been 
described. It was reported that staurosporine from Streptomyces staurosporeus induced the A549 cells spindle 
and triangle shape to change to a round shape [199]. Another study reported Pseudomonas aeruginosa strains 
inducing cytopathic effects, such as cell rounding, in A549 cells [200]. 
The occurrence of cell agglutination clumps is observed in A549 cultures incubated with P. aeruginosa 
strains virulent factors, as previously observed in L929 cultures (Figure 23). Although the supernatants from 
HB13 strain did not induce any visible agglutination in A549 cells, the supernatants from PAO1 and HB15 
strains had a significant impact in their highest concentration (20.50 µg/ml). The formation of agglutination 
clumps appears to be occurring in a time- and concentration-dependent manner, where the number of cell 
agglomerates grows along time. With the exception of the highest concentration of the supernatant of HB15 
strain, where the damaging level caused by the virulent factors present in the supernatant appears to impair the 
formation of cell agglomerates. The agglutination clumps observed in A549 cells are more distinct and extended 
than in L929 cells, suggesting that in A549 cells cell-to-cell communication is more susceptible to the P. 
aeruginosa virulence factors. 
One of the observed morphological alterations in A549 cells induced by the supernatants of the P. 
aeruginosa strains that stands out is cellular blebbing and formation of apoptotic bodies, and also cell lysis, in 
a time- and concentration-dependent manner (Figure 23). The cell blebs and apoptotic bodies are 
distinguishable in size and shape from the lamellar cell bodies of A549 cells, observable in Figure 23, where 
intracellular microvesicles, with function of storage of pulmonary surfactant, can be found [201]. Similar to what 
was observed in L929 cell cultures incubated with the supernatants of the P. aeruginosa strains, the emergence 
of cellular vesicles in A549 cells occurred in a time- and concentration-dependent manner, most evidently in the 
PAO1 and HB15 strains. These results, once more, correlate cytotoxicity of the strains with their level of effect 
on morphological alterations. The HB15 strain displayed the most aggressive morphological alteration in A549 
cells, causing a substantial number of blebbing cells at the concentration 3.42 µg/ml after 72h of incubation, 
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and at the highest concentration (20.50 µg/ml) after 48h of incubation the A549 cell culture displayed an 
extensive number of blebbing and cells undergoing lysis.  
As previously observed in L929 cells, these morphologic alterations support the suggestion that these 
cells also underwent apoptosis under influence of virulence factors of the P. aeruginosa strains, despite the 
number of cells killed through lysis. Evidences of P. aeruginosa inducing A549 cells to undergo apoptosis had 
been already reported [202], [203]. For instance, in 2013, it was reported that P. aeruginosa’s LPS induces 
A549 cells into apoptosis [151]. In order to strengthen the analysis of these morphological alterations in A549 
cells, fluorescence microscopy was performed again on A549 cell cultures incubated with supernatants from 
the P. aeruginosa strains. The same staining procedure used in L929 cells was applied to the A549 cells. 
Concentration and incubation time was settled, as previously in L929 cells, and A549 cell culture were let grow 
in 24 well plates for 24h. The testing groups were incubated with 3.42 µg/ml of the strains supernatants. After 
incubation, the samples were transferred into cover slips for observation under the microscope (Figure 24). 
 
Figure 24 - Fluorescence microscopy of A549 cells to study morphological features induced by Pseudomonas 
aeruginosa strains. The cytoskeleton of the A549 cells are stained with the probe Phalloidin Alexa Fluor 568 (red) and the nucleus 
of the L929 cells are stained with the bisbenzimide dye Hoechst 34580 (blue). The merging of the individual stained components 
provides a composite image refining the cellular morphology observation. The A549 control cells cultured in DMEM medium, grown 
for 24h and transferred in cover slips for prior microscopy observation are represented as “Control ( – )”. The A549 cells incubated 
with the supernatants of the P. aeruginosa strains are represented as “PAO1”, “HB15” and “HB13”. All cells were incubated with 
3.42 µg/ml of P. aeruginosa strains supernatants during 24h, respectively and transferred in cover slips for prior microscopy 
observation. The white arrows points to noteworthy morphological features, in the up row (Phalloidin Alexa Fluor 568) indicates a 
visible cellular blebbing and in the middle row (Hoechst 34580) indicates a visible nuclear fragmentation. The scale bar represents 
25 µm length. 
The resulting images display A549 cells with distinct red stained cytoskeleton and distinct blue stained 
nuclei. In the control group are visible confluent cells exhibiting distinct actin filaments and single nuclei (Figure 
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24). The A549 cell cultures incubated with supernatants from the P. aeruginosa strains presented visible 
morphological alterations. In A549 cells incubated with 3.42 µg/ml of PAO1 strain supernatant is visible the 
reduction of F-actin density in some cells as well as actin cytoskeleton disorganization. Also cell-to-cell junctions 
appear diminished. Significant changes in the nucleus structure were not observable.  
The A549 cells incubated with 3.42 µg/ml of HB15 strain supernatant display more conspicuous 
morphological alterations. There is less cell population density and the cells display cellular blebs and nuclear 
fragmentation, as indicated by white arrows in Figure 24. These are hallmarks of apoptosis, which indicates that 
HB15 secreted virulence factors is inducing it. In further literature, it was already described that P. aeruginosa 
virulence factors induce cytoskeleton reorganization, cellular blebbing, nuclear fragmentation and subsequently 
apoptosis in A549 cells [151]. These findings, once again, match the results obtained from the contrast-phase 
microscopy of the A549 cells incubates with the supernatants of the P. aeruginosa strains, indicating that the 
cells underwent apoptosis.  
In A549 cells incubated with 3.42 µg/ml of HB13 strain supernatant the morphological changes were 
less significant than what was observed with the other two strains. However it can also be seen, in some cells, 
diminishing F-actin density as well as evidences of F-actin reorganization (Figure 24).  
The visualization of these A549 cells with fluorescence microscopy showed to be a viable resource to 
confirm detailed cellular morphological evidences occurring during the incubation with secreted virulence factors 
from these three P. aeruginosa strains, translating into solid information about cellular processes during 
infection. Once again, time and cost-effective limitation barred the use of an extended time/concentration range 
which could provide more interesting results. 
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3.7. Final considerations and future perspectives 
The exponential arising of new variants and strains of pathogenic bacteria has commanded researchers’ 
attention towards the characterization of the pathogenic potential of these new threats. Pseudomonas 
aeruginosa specie has been considered as one of the most concerning nosocomial bacterial species, with a 
wide range of strains and variants comprehending high levels of pathogenicity and/or high levels of resistance 
[1]. 
The problematic of this thesis work results from an interlinked system between the model, the 
experiment and the output, in order to attempt answer the biological question posed.  
Here, the characterization of the relatively recent P. aeruginosa clinical isolates, HB13 and HB15 
strains, led this thesis work to converge its study focus to the pathogenic potential. 
Therefore, the pathogenic potential characterization of these strains required a reliable design of a 
preliminary interface in order to produce a significant output that later help disclose sophisticated and complex 
molecular mechanism behind the infection mechanisms of these strains.  
The HB13 and HB15 strains had been previously described to have significantly different features 
between them, regarding genomics, pathogenicity and antibiotic resistance [94], [204]. Thus, it became 
reasonable to invest in a close approach concerning their pathogenicity. Alongside, the introduction of the 
reference strain PAO1 served as a comparing rail in this thesis. 
One of the main achievements of this thesis work was the performance of an initial concentration 
screening of the virulence factors from the P. aeruginosa strains on a cell culture. Without existing data about 
quantities of virulence factors that induce notable cellular damage, this procedure was suitable, not only to 
access the point where a concentration start to be toxic towards the cells, but also to give an initial insight on 
the evolution of toxicity dependent of the virulence factors’ concentration. 
The wide-known L929 and A549 cell line, used as host models for a variety of studies in P. aeruginosa 
[124], [127], [144], [149]–[153], in this thesis work were suitable models, not only to assess the HB13 and 
HB15 cytotoxicity, but also to examine different levels of cytotoxicity induced in cells from different tracts.  
In the cytotoxicity tests, carried in these cell lines, it was possible to identify considerable differences 
between the HB13 and HB15 strains. It was stated that HB15 is significantly more cytotoxic than HB13, 
confirming previous literature referring the same divergences about pathogenicity of these strains [94], [204]. 
Nevertheless, the HB13 strain still showed considerable cytotoxicity, while possessing the feature of pan-
resistance which places this strain as a dangerous resistant pathogen in hospital facilities. In both animal cell 
models, the concentrations obtained through dilutions of the original samples of the P. aeruginosa strains 
supernatants, revealed astonishing high cellular toxicity rates, sometimes even higher than the positive control 
(30% DMSO), which indicates the considerable pathogenicity of these strains, mainly the HB15 strain.  
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Pairing with the cytotoxicity tests, microscopy observations took place to inquire possible morphological 
alterations, which reveal considerable cell damaging, cell population organized in cell aggregates, loss of cellular 
shape, presence of cellular blebbing and evidences of formation of apoptotic bodies, as well as cytoskeleton 
disorganization and nuclear fragmentation confirmed by fluorescence microscopy. Here, the HB13 and HB15 
displayed, also, significant differences regarding their capacity to induce morphological alterations. The HB15 
strains revealed to easily induce drastic alterations in the cells morphology, whilst the HB13 strain didn’t showed 
significant alterations, been only visible signs of loss of cellular shape and presence of cellular blebbing at the 
highest concentration after 72h of incubation. These findings helped to gain further insights into the biological 
processes behind the induced cytotoxicity in these cell lines. Cellular blebbing and formation of apoptotic bodies 
suggests that cellular death is the result of the tested cells undergoing apoptosis induced by the secreted 
virulence factors of the strains. Nevertheless, cellular death studies and apoptosis assays should be performed 
in order to better characterize the cell death process occurring here. 
Regarding the intracellular processes that might be associated with the cytotoxicity levels, initiating steps 
during this thesis work have already been taken in order to ascertain if cellular oxidative stress is induced by the 
virulence factors of P. aeruginosa strains. One type of cellular response to pathogenic agents is the production 
of reactive oxygen species (ROS) causing cellular oxidative stress [151], therefore a dichlorofluorescein (DCF) 
assay was performed, as a straightforward and reliable means to assess cellular oxidative stress [205]. A549 
cells were selected to perform the assay. The cells were incubated 1 hour and 4 hours with 3.42 µg/ml of 
culture supernatants from the P. aeruginosa strains, plus a negative control (A549 cells growing with only culture 
medium) and a H2O2 control (A549 cells incubated with 2mM of H2O2). The assay outcome was measured in 
relative fluorescence intensity, and it was evaluated comparing the relative fluorescence intensities of the cells 
incubated with the P. aeruginosa strains supernatants with the negative control, presented in appendix. In 
summary, the oxidative stress study was insufficiently designed though it gave availed results stating that in the 
early moments of the cells incubation with the secreted virulence factors the oxidative stress is enhanced, one 
of the causes that damage the cells and lead to cellular unviability, and further oxidative stress studies should 
be performed in order to obtain better results. 
Regarding the experimental design of this thesis work, the pathogenicity of the HB13 and HB15 was 
accessed not from co-culture with the bacteria and the cell lines, but rather, incubation of the cells with 
supernatants from the bacterial culture. One of the problems of this experimental procedure is that virulence 
genes may not be expressed due to lack of an infection context. However, the results of this thesis showed that 
the bacterial culture of the P. aeruginosa strains in controlled conditions and medium in a laboratory flask for 
optimal growth, without any infection stimuli, which could provide a pathogenic response, still revealed an 
overwhelming abundant secretion of extracellular products which caused significant cellular damage in the 
tested cell lines, L929 and A549. These findings suggest that the bacterial species P. aeruginosa is capable of 
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displaying a battery of virulence factors without an infection context being absolutely required. Given the 
virulence factors are produced by bacteria to subvert the host defences, it is plausible to say that P. aeruginosa 
is always predisposed to subvert host defences even without effective contact with the host.  
The strategy used in this thesis work to characterize the pathogenic potential of HB13 and HB15, had 
the main objective of using the initial concentration screening of virulence factors to access the cytotoxicity and 
subsequent cell morphological alterations, in a very straightforward procedure comparing the two strains in his 
capacity of inducing cell damage. As this strategy consist in a simple and straightforward system, it revealed 
suitable for easily find concentrations of virulence factors toxic towards the cell, and so, establish a comparison 
reference between HB13 and HB15 pathogenicity. Although, a more refine set of concentrations is needed to 
answer significant biologic question such as the median lethal dose. More concentrations and a more narrow 
range in a concentration set should be applied in order to determine reliable and absolute values of lethality.  
The output of the pathogenic studies in L929 and A549 cell lines revealed different levels of cell 
damaging. In general, the L929 cells were much more susceptible to the virulence factors from PAO1, HB13 
and HB15 strains than the A549 cells. These findings may infer that skin infections could be more persistent 
than lung infections. However, it is needed more data about the molecular mechanisms underlying the host-
pathogen interactions to inquire about the susceptibilities of the cell lines used.  
The L929 and the A549 cells morphologic alterations induced by HB13 and HB15 shed some insight 
iinto the possible infection mechanism of these strains. For instance, it is known that P. aeruginosa uses a 
variety of proteases, such as LasB, to disrupt the extracellular matrix, which in cell cultures causes cell 
dissociation. The HB15 strain induced noteworthy cellular dissociation unlike the HB13 strain, which suggest 
that HB13 may underexpress or even not express at all the LasB protease. Also, it is known that LasB mutants 
are less pathogenic than its counterparts [25], [38].  
Other molecular machinery required for cell damaging and cell death may be underexpress or absent 
in HB13. In comparison with HB15 strain, HB13 didn’t revealed significant intracellular morphologic changes, 
such as disruption of the cytoskeleton, which may be linked to an underexpression of the T3SS, or the set of 
exoenzymes. The disruption of the cytoskeleton may lead to programmed cell death, which also may explains 
the lower level of cytotoxicity by HB13.  
These indications suggests an existence of different sets of virulence in each strain, HB13 and HB15. 
In future work, regarding comparative studies of these sets of virulence factors, a proteomic approach could 
give a deep insight in the molecular process behind the virulence expression pattern in these strains. 
In general, this thesis work opened the way for insights into the pathogenicity of these strains. Although, 
further work should be conducted in order to achieve a fully understanding of the infection mechanisms behind 
the pathogenicity of HB13 and HB15. New cytotoxicity assays, oxidative stress tests, intracellular pH variations 
and nuclear fragmentation studies should be designed for further approaches. In the future, the possibility of an 
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integration of a whole system model should be envisaged for validation of the output in an actual infection 
situation. 
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5.1. Appendix 1 – pH measurements of the supernatant concentrations of the 
Pseudomonas aeruginosa strains 
 
Figure A 1 - pH measurements of the supernatant concentrations of the Pseudomonas aeruginosa strains. The graphic 
exhibits pH measurements of the highest and lowest concentration of the supernatants of the P. aeruginosa strains, PAO1, HB15 and 
HB13, from the two time points of bacterial growth (t1 = 24h, t2 = 48h) from the serial dilutions made. Grey bars represent the 
supernatant P. aeruginosa strains dilution concentrations, light grey for the t1 and hard grey for the t2). The pH measurements for the 
DMEM medium and LB medium are also shown represent by the white bars. The resulting data was statistically analysed by a One-
way ANOVA with Tukey test where P value was set for: P <0.05. Significant values comparing to the negative control were represented 
in the graphic as, * for P <0.05, ** for P <0.01 and *** for P <0.001. 
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5.2. Annex 2 – Cytotoxicity of Pseudomonas aeruginosa strains in L929 cell availed in all concentrations tested 
 
Figure A 2 - Cytotoxicity of the Pseudomonas aeruginosa HB15 strain culture supernatant on L929 cells. The graphic displays the results of the MTT assay performed on L929 cells 
submitted to a range of total protein concentrations of the culture supernatants of the Pseudomonas aeruginosa HB15 strain, grown in two different time setups, represented in the graphic as t1 and t2, 
respectively 24 hours of bacterial culture growth and 48 hours of bacterial culture growth, in cell viability percentage represented by bars with the respective standard deviation represented by vertical 
lines for a number of replicas n=2. The bar legend represents the end times of incubation (24h, 48h and 72h) with the supernatants. The controls are presented in the graphic represented as “CONTROL”. 
The negative control has the constant value of 100% of viability for each end times of incubation and not shown in the graphic. The positive control is represented as “+” on the graphic. The controls of 
the bacterial culture media (LB) are represented on the graphic as “LB 25%” and “LB 7.5%”. The resulting data was statistically analysed by a One-way ANOVA with Tukey test where P value was set for: 
P <0.05. Significant values comparing to the negative control were represented in the graphic as, * for P <0.05, ** for P <0.01 and *** for P <0.001.   
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Figure A 3 - Cytotoxicity of the Pseudomonas aeruginosa HB13 strain culture supernatant on L929 cells. The graphic displays the results of the MTT assay performed on L929 cells 
submitted to a range of total protein concentrations of the culture supernatants of the Pseudomonas aeruginosa HB13 strain, grown in two different time setups, represented in the graphic as t1 and t2, 
respectively 24 hours of bacterial culture growth and 48 hours of bacterial culture growth, in cell viability percentage represented by bars with the respective standard deviation represented by vertical 
lines for a number of replicas n=2. The bar legend represents the end times of incubation (24h, 48h and 72h) with the supernatants. The controls are presented in the graphic represented as “CONTROL”. 
The negative control has the constant value of 100% of viability for each end times of incubation and not shown in the graphic. The positive control is represented as “+” on the graphic. The controls of 
the bacterial culture media (LB) are represented on the graphic as “LB 25%” and “LB 7.5%”. The resulting data was statistically analysed by a One-way ANOVA with Tukey test where P value was set for: 
P <0.05. Significant values comparing to the negative control were represented in the graphic as, * for P <0.05, ** for P <0.01 and *** for P <0.001.   
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Figure A 4 - Cytotoxicity of the Pseudomonas aeruginosa PAO1 strain culture supernatant on L929 cells. The graphic displays the results of the MTT assay performed on L929 cells 
submitted to a range of total protein concentrations of the culture supernatants of the Pseudomonas aeruginosa PAO1 strain, grown in two different time setups, represented in the graphic as t1 and t2, 
respectively 24 hours of bacterial culture growth and 48 hours of bacterial culture growth, in cell viability percentage represented by bars with the respective standard deviation represented by vertical 
lines for a number of replicas n=2. The bar legend represents the end times of incubation (24h, 48h and 72h) with the supernatants. The controls are presented in the graphic represented as “CONTROL”. 
The negative control has the constant value of 100% of viability for each end times of incubation and not shown in the graphic. The positive control is represented as “+” on the graphic. The controls of 
the bacterial culture media (LB) are represented on the graphic as “LB 25%” and “LB 7.5%”. The resulting data was statistically analysed by a One-way ANOVA with Tukey test where P value was set for: 
P <0.05. Significant values comparing to the negative control were represented in the graphic as, * for P <0.05, ** for P <0.01 and *** for P <0.001.  
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5.3. Annex 3 – Cytotoxicity of Pseudomonas aeruginosa strains in A549 cell availed in all concentrations tested 
 
Figure A 5 - Cytotoxicity of the Pseudomonas aeruginosa HB15 strain culture supernatant on A549 cells. The graphic displays the results of the MTT assay performed on A549 cells 
submitted to a range of total protein concentrations of the culture supernatants of the Pseudomonas aeruginosa HB15 strain, grown in two different time setups, represented in the graphic as t1 and t2, 
respectively 24 hours of bacterial culture growth and 48 hours of bacterial culture growth, in cell viability percentage represented by bars with the respective standard deviation represented by vertical 
lines for a number of replicas n=2. The bar legend represents the end times of incubation (24h, 48h and 72h) with the supernatants. The controls are presented in the graphic represented as “CONTROL”. 
The negative control has the constant value of 100% of viability for each end times of incubation and not shown in the graphic. The positive control is represented as “+” on the graphic. The controls of 
the bacterial culture media (LB) are represented on the graphic as “LB 25%” and “LB 7.5%”. The resulting data was statistically analysed by a One-way ANOVA with Tukey test where P value was set for: 
P <0.05. Significant values comparing to the negative control were represented in the graphic as, * for P <0.05, ** for P <0.01 and *** for P <0.001.   
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Figure A 6 - Cytotoxicity of the Pseudomonas aeruginosa HB13 strain culture supernatant on A549 cells. The graphic displays the results of the MTT assay performed on A549 cells 
submitted to a range of total protein concentrations of the culture supernatants of the Pseudomonas aeruginosa HB13 strain, grown in two different time setups, represented in the graphic as t1 and t2, 
respectively 24 hours of bacterial culture growth and 48 hours of bacterial culture growth, in cell viability percentage represented by bars with the respective standard deviation represented by vertical 
lines for a number of replicas n=2. The bar legend represents the end times of incubation (24h, 48h and 72h) with the supernatants. The controls are presented in the graphic represented as “CONTROL”. 
The negative control has the constant value of 100% of viability for each end times of incubation and not shown in the graphic. The positive control is represented as “+” on the graphic. The controls of 
the bacterial culture media (LB) are represented on the graphic as “LB 25%” and “LB 7.5%”. The resulting data was statistically analysed by a One-way ANOVA with Tukey test where P value was set for: 
P <0.05. Significant values comparing to the negative control were represented in the graphic as, * for P <0.05, ** for P <0.01 and *** for P <0.001.   
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Figure A 7 - Cytotoxicity of the Pseudomonas aeruginosa PAO1 strain culture supernatant on A549 cells. The graphic displays the results of the MTT assay performed on A549 cells 
submitted to a range of total protein concentrations of the culture supernatants of the Pseudomonas aeruginosa PAO1 strain, grown in two different time setups, represented in the graphic as t1 and t2, 
respectively 24 hours of bacterial culture growth and 48 hours of bacterial culture growth, in cell viability percentage represented by bars with the respective standard deviation represented by vertical 
lines for a number of replicas n=2. The bar legend represents the end times of incubation (24h, 48h and 72h) with the supernatants. The controls are presented in the graphic represented as “CONTROL”. 
The negative control has the constant value of 100% of viability for each end times of incubation and not shown in the graphic. The positive control is represented as “+” on the graphic. The controls of 
the bacterial culture media (LB) are represented on the graphic as “LB 25%” and “LB 7.5%”. The resulting data was statistically analysed by a One-way ANOVA with Tukey test where P value was set for: 
P <0.05. Significant values comparing to the negative control were represented in the graphic as, * for P <0.05, ** for P <0.01 and *** for P <0.001.   
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5.4. Annex 4 - L929 and A549 cell line culture growth through time 
 
Figure A 8 - L929 cell line culture growth through time. Contrast phase microscope shot of L929 cell culture grown in 96 well 
plate at 24h, 48h and 72h. The image show abundant distinguishable fibroblasts with spindle and stellate shape and some round 
shape fibroblast. The scale bar is set for 200 µm.  
 
Figure A 9 – A549 cell line culture growth through time. Contrast phase microscope shot of A549 cell culture grown in 96 
well plate at 24h, 48h and 72h. The image show abundant distinguishable fibroblasts with spindle and stellate shape and some round 
shape fibroblast. The scale bar is set for 200 µm.   
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5.5. Annex 5 - Oxidative stress induced by Pseudomonas aeruginosa strains culture 
supernatants 
The DCF assay outcome, shows all the fluorescence intensities of the cells incubated 1 hour with P. 
aeruginosa strains supernatants superior to the negative control, indicating that P. aeruginosa strains 
supernatants are inducing oxidative stress in the cells. The H2O2 control exhibit an estimated 3 times 
fluorescence intensity than the fluorescence intensity in the negative control, establishing that the cells 
underwent oxidative stress in presence of a strong ROS. Fluorescence intensity caused by the P. aeruginosa 
strains supernatants didn’t show considerable variances between each strain. 
The fluorescence intensities of the cells incubated 4 hour with P. aeruginosa strains supernatants 
superior revealed no considerable differences with the negative control, plus, the H2O2 control exhibits also no 
considerable differences between the P. aeruginosa strains or the negative control fluorescence intensities.  
Comparing the two incubation times (1h and 4h), it is observable a drop in fluorescence intensity after 
4 hours of incubation in the P. aeruginosa strains group. In the negative control the fluorescence intensity raised 
after 4 hours of incubation, and in the H2O2 control decreased considerably (Figure A 10). 
 
Figure A 10 -- Oxidative stress induced by Pseudomonas aeruginosa strains culture supernatant in A549 cells. The 
graphic displays the results of the DCF assay performed on A549 cells submitted 3.42 µg/ml total protein of the culture supernatants 
of the Pseudomonas aeruginosa strains (PAO1, HB15 and HB13) in fluorescence intensity (absolute units) obtained from fluorimetry 
using an emission wavelength of 538nm and excitation wavelength of 485nm, with the respective standard deviation represented by 
vertical lines for a number of replicas n=2. The bar legend represents the end times of incubation (white bar = 1h and grey bar = 4h) 
with the supernatants. The controls are presented in the graphic represented as “CONTROL”. The negative control represents the 
fluorescence intensity from the oxidative stress of the cells growing with only DMEM medium. The H2O2- control represent represents 
the fluorescence intensity from the oxidative stress of the cells growing with 2mM H2O2. The resulting data was statistically analysed 
by a One-way ANOVA with Tukey test where P value was set for: P <0.05, for n=2 independent experiments 
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The analysis of the DCF assay results suggests that oxidative stress was occurring in the cells incubated 
the P. aeruginosa strains supernatants, tough it was expected that the oxidative stress increased trough time, 
not verified in the fluorescence intensity results after 4 hours of incubation. These incongruous results suggest 
that conceivably after 4 hours of incubation the cells are already in a death phase, which decreases the 
fluorescence signal given that there are fewer cells to do the intercellular hydroxylation and oxidization of the 
DCFH-DA specie which than becomes fluorescent. In further literature, it is shown A549 cells incubated with 
pathogenic bacteria through shorter time lengths, where fluorescence intensity increases in a time-dependent 
manner until approximately 2 hours of incubation, after that the fluorescence intensity starts to drop [206]. 
Other literature refers short incubation times, around 1 hour of incubation, in A549 cells with virulent agents 
[207], [208]. Furthermore, the H2O2 control compassing the testing groups, appears in literature with shorter 
incubation times also, lesser than 1 hour [209].  
Analysing the DCF assay experiment design and the previous literature, it should be chosen shorter 
incubation times to evaluate the oxidative stress occurring in the A549 cells in order to achieve more significant 
results. Furthermore, time and cost-effective limitation restrained the use of the two cellular models (L929 and 
A549), thus the A549 cells was selected because it is a more recurrent model used to analyse oxidative stress 
on these conditions, there is also profuse literature concerning oxidative stress studies in A549 cells in bacteria 
infectious situation and it is a model more suitable to achieve relevant information regarding respiratory tract 
infection panorama caused by Pseudomonas aeruginosa [210], [211]. Also time and cost-effective limitation 
restrained the use of a more extended time/concentration range, which could provide more interesting results 
regarding the oxidative stress depending of concentration and incubation time. Nevertheless, this oxidative stress 
study findings indicates that oxidative stress is enhanced on the A549 cells in the early times prior incubation 
with the P. aeruginosa strains supernatants. 
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